Retinal vascular occlusion

H7_RETIVASCOCCLUSION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H34 Cause of death: ICD-10 — H34 2 out of 7 registries used, show all original rules.	5078
4. Check minimum number of events None	5078
5. Include endpoints None	5078
6. Filter based on genotype QC (FinnGen only)	4922

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H30-H36
Name in latin: Occlusiones vasculares retinae

NAME	H7_RETIVASCOCCLUSION
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H34
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H34
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Retinal vascular occlusion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Transient retinal artery occlusion

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37188	18641	18366
Only index persons	34152	17322	16830
Unadjusted period prevalence (%)
Whole population	0.52	0.53	0.51
Only index persons	0.64	0.64	0.64
Median age at first event (years)
Whole population	72.34	74.37	70.25
Only index persons	71.86	73.87	69.79

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4922	2247	2675
Unadjusted period prevalence (%)	1.03	0.80	1.23
Median age at first event (years)	70.21	69.85	70.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5078: Matched controls
50780

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.6

322.8

1365

4702

CKC10

NOMESCO Finland

Local photocoagulation of retina

97.0

307.7

258

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

170.5

307.7

165

XCH00

NOMESCO Finland

Eye pressure measurement

6.6

307.7

556

927

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

13.8

307.7

1082

977

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

120.5

307.7

252

H43.1

ICD-10 Finland

Vitreous haemorrhage

23.6

307.7

433

200

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

597.5

307.7

1707

WX140

NOMESCO Finland

Parabulbar anesthesy

9.7

307.7

457

515

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.8

307.7

1413

4730

XCD20

NOMESCO Finland

Photoangiography of eye

113.2

307.7

454

XCK10

NOMESCO Finland

Photography of fundus of eye

6.4

307.7

1212

2355

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

43.0

307.7

273

CKC12

NOMESCO Finland

Photocoagulation of retina

216.7

307.7

923

H34.1

ICD-10 Finland

Central retinal artery occlusion

2931.1

307.7

784

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

103.4

307.7

495

H34.8

ICD-10 Finland

Other retinal vascular occlusions

6896.8

307.7

3712

CKC15

NOMESCO Finland

Panretinal photocoagulation

183.4

307.7

177

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

16.9

307.7

386

246

XCW99

NOMESCO Finland

Other investigative procedure of eye

8.3

307.7

1394

2211

S01ED51

ATC

timolol, combinations; ophthalmic

5.3

307.7

1054

2404

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

13.0

307.7

1505

1595

H34.2

ICD-10 Finland

Other retinal artery occlusions

2274.2

307.7

817

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

36.0

307.7

340

101

114

Kela drug reimbursment

Glaucoma

3.9

298.2

1054

3205

H33.3

ICD-10 Finland

Retinal breaks without detachment

149.2

290.7

145

XCK00

NOMESCO Finland

Perimetry

4.8

288.1

721

1689

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

22.6

269.6

198

S01EA05

ATC

brimonidine; ophthalmic

6.9

249.6

404

630

S01EE01

ATC

latanoprost; ophthalmic

4.1

243.5

756

2079

ZX198

NOMESCO Finland

Other local administration

26.1

240.8

167

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

415.1

239.9

239

S01EC01

ATC

acetazolamide; systemic

7.7

220.5

320

442

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

4.3

196.4

557

1424

H36.01

ICD-10 Finland

Diabetic maculopathy

79.2

189.2

101

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

22.0

187.6

139

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

82.4

182.7

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

94.7

178.2

S01EC04

ATC

brinzolamide; ophthalmic

4.4

177.8

482

1188

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.3

169.9

2481

15134

H36.00

ICD-10 Finland

Diabetic background retinopathy

54.3

168.9

H33.0

ICD-10 Finland

Retinal detachment with retinal break

287.2

163.7

166

H3601, E113,

ICD-10 Finland

+∞

159.2

152

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

45.8

152.8

H25.1

ICD-10 Finland

Senile nuclear cataract

2.2

150.7

2141

12744

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

502.3

148.3

147

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

5.4

144.9

299

586

H53.1

ICD-10 Finland

Subjective visual disturbances

3.6

138.2

491

1461

H53.9

ICD-10 Finland

Visual disturbance, unspecified

4.8

134.5

313

680

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.1

133.1

2190

13608

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

23.0

130.9

S01EA03

ATC

apraclonidine; ophthalmic

11.1

128.0

137

127

CKD40

NOMESCO Finland

Endophotocoagulation of retina

267.3

127.7

130

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

60.0

127.1

S01EC54

ATC

brinzolamide, combinations; ophthalmic

7.0

125.1

195

290

H43.8

ICD-10 Finland

Other disorders of vitreous body

3.0

124.5

621

2266

H3600, E113,

ICD-10 Finland

+∞

123.4

118

ZXA10

NOMESCO Finland

Bilateral

2.3

123.3

1207

6097

XCW10

NOMESCO Finland

Assessment of vision

8.9

122.9

155

180

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.3

122.8

497

1604

AA1AD

NOMESCO Finland

CT of head and brain

2.0

121.4

1877

11307

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.7

118.7

226

411

H40.0

ICD-10 Finland

Glaucoma suspect

2.9

118.4

613

2281

S01ED01

ATC

timolol; ophthalmic

3.9

115.1

361

984

H54.4

ICD-10 Finland

Blindness, monocular

27.3

114.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.7

111.5

675

2723

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

109.5

2422

16342

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.4

108.9

285

679

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

32.2

108.4

B01AC04

ATC

clopidogrel; oral

2.1

108.2

1300

7078

CS494

NOMESCO Finland

Other visual field testing

4.8

106.6

245

526

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

16.8

106.4

CKC20

NOMESCO Finland

Cryopexy of undetached retina

222.7

106.0

109

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

44.8

104.6

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

354.5

104.6

105

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.6

103.1

356

1035

H26.4

ICD-10 Finland

After-cataract

2.5

102.2

759

3371

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

100.8

3689

29008

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

3.9

97.1

304

826

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.1

90.4

192

385

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

138.3

89.3

H35.8

ICD-10 Finland

Other specified retinal disorders

187.3

88.5

Z5132

NOMESCO Finland

Nursing associate professional

12.4

83.0

H33.5

ICD-10 Finland

Other retinal detachments

19.9

81.8

H34.0

ICD-10 Finland

Transient retinal artery occlusion

811.3

81.7

H3603, E113,

ICD-10 Finland

+∞

81.5

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

6.5

81.3

134

211

G45.3

ICD-10 Finland

Amaurosis fugax

4.5

80.1

202

467

S01EE03

ATC

bimatoprost; ophthalmic

4.0

79.8

232

597

H53.4

ICD-10 Finland

Visual field defects

4.6

79.7

195

440

C08CA01

ATC

amlodipine; oral

1.7

79.7

2386

17092

S01EC03

ATC

dorzolamide; ophthalmic

4.9

78.8

178

376

S01EX03, ,

ATC

4.0

77.5

228

592

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

15.2

75.1

C10AA05

ATC

atorvastatin; oral

1.7

74.7

2484

18200

H35.6

ICD-10 Finland

Retinal haemorrhage

257.4

74.6

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

3.3

74.2

286

890

1LA05, ,

NOMESCO Finland

+∞

73.1

S01EE05

ATC

tafluprost; ophthalmic

3.2

72.4

306

1007

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.4

70.5

526

2321

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.3

69.5

182

433

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

68.0

854

4637

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

65.3

536

2463

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

8.3

64.5

104

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

13.1

63.9

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

98.5

62.0

H35.36

ICD-10 Finland

Macular cyst

316.7

61.5

F05

ICPC

Visual disturbance other

3.6

61.1

204

578

H40.9

ICD-10 Finland

Glaucoma, unspecified

3.9

61.0

182

477

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

9.0

60.2

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

76.7

60.1

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

7.4

59.7

120

ZXA05

NOMESCO Finland

Left side

1.7

59.2

1390

9123

S01EE04

ATC

travoprost; ophthalmic

3.7

59.2

195

547

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

58.4

2562

19683

PA6AD

NOMESCO Finland

CT of neck arteries

3.4

58.1

216

656

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

10.4

57.0

H35.9

ICD-10 Finland

Retinal disorder, unspecified

25.2

56.9

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

6.6

56.9

139

H35.37

ICD-10 Finland

Macular holes

146.7

54.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.1

54.7

161

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

54.7

1320

8698

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

9.4

54.5

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.5

54.3

189

550

Z3231

NOMESCO Finland

Registered nurse

1.7

53.3

1432

9695

H25.8

ICD-10 Finland

Other senile cataract

1.9

53.1

770

4361

ZXA00

NOMESCO Finland

Right side

1.7

52.9

1467

10010

N02BE01

ATC

paracetamol; systemic, rectal

1.9

52.7

4411

39368

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

523.4

52.6

C10AA01

ATC

simvastatin; oral

1.6

51.9

2622

20593

H3603, E103,

ICD-10 Finland

+∞

50.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

49.8

359

1553

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

3.6

49.0

164

465

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

48.7

656

3619

A10AB05

ATC

insulin aspart; parenteral

2.3

48.0

400

1842

S01BC03

ATC

diclofenac; ophthalmic

3.8

47.8

150

407

C07AB07

ATC

bisoprolol; oral

1.5

46.6

2817

22781

H25.0

ICD-10 Finland

Senile incipient cataract

2.2

45.4

413

1970

C03CA01

ATC

furosemide; systemic

1.5

45.4

2060

15635

H35.7

ICD-10 Finland

Separation of retinal layers

451.8

45.3

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.0

44.9

205

704

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.3

44.0

169

524

H3601, E103,

ICD-10 Finland

+∞

43.8

A10AE04

ATC

insulin glargine; parenteral

2.0

42.6

499

2618

H3600, E103,

ICD-10 Finland

+∞

41.7

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.4

41.3

CHD00

NOMESCO Finland

Laser trabeculoplasty

3.9

39.5

117

305

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

58.0

39.3

A10AA01, ,

ATC

4.7

39.2

193

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

38.7

1465

10603

A98

ICPC

Health maint/preventive medicine

1.8

37.8

4511

41394

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

37.4

973

6449

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

37.3

1032

6943

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

37.1

632

3736

T90

ICPC

Diabetes non-insulin dependent

1.6

37.0

1272

8997

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

37.0

453

2409

A10AB01

ATC

insulin (human); parenteral

3.4

36.4

130

385

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

36.0

143

453

S01BC05

ATC

ketorolac; ophthalmic

2.4

35.9

256

1101

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

35.8

1489

10961

H54.5

ICD-10 Finland

Severe visual impairment, monocular

7.8

35.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

35.4

1269

9045

SPAT1263

SPAT

Sampling

1.5

35.2

1984

15495

C08CA13

ATC

lercanidipine; oral

1.7

35.2

838

5424

F29

ICPC

Eye symptom/complaint other

2.0

35.0

436

2330

CKD15

NOMESCO Finland

Injection of vitreous substitute

181.3

34.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

34.5

1138

7956

A10AE05

ATC

insulin detemir; parenteral

2.3

34.5

263

1164

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

34.4

1565

11709

WX002

NOMESCO Finland

Sedation and analgesia

1.6

34.2

971

6556

A10AC01

ATC

insulin (human); parenteral

2.0

33.1

363

1856

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

74.7

32.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

32.6

2988

25380

C09AA05

ATC

ramipril; oral

1.5

32.5

1485

11094

H47.1

ICD-10 Finland

Papilloedema, unspecified

7.7

32.3

H20.1

ICD-10 Finland

Chronic iridocyclitis

5.6

32.0

111

205

Kela drug reimbursment

Chronic hypertension

1.5

31.9

1697

13046

WX142

NOMESCO Finland

Sub-tenon anesthesy

7.4

31.8

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

166.1

31.7

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

60.4

31.1

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

31.0

1276

9322

J01DB01

ATC

cefalexin; oral

1.5

30.9

3807

33970

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

314.8

30.9

CKD20

NOMESCO Finland

Removal of vitreous body substitute

161.0

30.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

30.4

399

2169

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

30.3

234

1042

A11CC03

ATC

alfacalcidol; systemic

2.9

30.1

146

519

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

30.0

447

2529

A02BC02

ATC

pantoprazole; systemic

1.4

29.8

3266

28402

127

Kela drug reimbursment

Transplant complication

4.4

29.7

174

S01ED02

ATC

betaxolol; ophthalmic

3.8

29.5

240

H40.11

ICD-10 Finland

Low pressure glaucoma

2.8

29.4

150

548

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

29.3

681

4364

H04AA01

ATC

glucagon; nasal, parenteral

5.0

29.1

125

A10AA02, ,

ATC

3.0

29.0

129

437

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

28.7

1324

9866

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

28.3

476

2794

CHD99

NOMESCO Finland

Other filtering operation

9.2

28.3

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

28.1

1457

11091

R53

ICD-10 Finland

Malaise and fatigue

1.5

27.8

1147

8354

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

27.5

1323

9921

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

27.5

137

494

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

27.3

137

496

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

27.2

1468

11243

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.8

27.1

129

T89

ICPC

Diabetes insulin dependent

2.9

27.0

132

471

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

4.1

26.4

173

C02AC05

ATC

moxonidine; oral

2.1

26.2

271

1354

R06.0

ICD-10 Finland

Dyspnoea

1.4

26.2

1357

10302

S18

ICPC

Laceration/cut

1.4

26.1

2178

17926

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

8.3

26.1

C01DA14

ATC

isosorbide mononitrate; oral

1.5

26.1

1079

7848

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.9

26.1

201

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

26.0

355

1953

H26.2

ICD-10 Finland

Complicated cataract

4.7

25.9

126

R42

ICD-10 Finland

Dizziness and giddiness

1.5

25.9

1181

8755

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

93.9

25.7

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

25.7

1033

7471

H53.8

ICD-10 Finland

Other visual disturbances

3.8

25.4

209

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.3

25.4

205

930

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

25.4

105

A10AB04

ATC

insulin lispro; parenteral

3.2

25.4

103

331

A10BA02

ATC

metformin; oral

1.4

25.4

1483

11491

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

25.3

495

3028

L28

ICPC

Limited function/disability (L)

1.5

24.7

1006

7286

B01AA03

ATC

warfarin; systemic

1.4

24.7

1268

9595

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.5

24.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

24.5

1010

7330

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

24.3

1380

10623

C08CA02

ATC

felodipine; oral

1.6

24.1

575

3699

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.0

24.1

172

C09CA01

ATC

losartan; oral

1.4

23.8

1317

10085

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

23.7

1055

7764

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

23.7

502

3134

J01CA04

ATC

amoxicillin; systemic

1.4

23.5

3559

31935

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

23.4

236

1168

K78

ICPC

Atrial fibrillation/flutter

1.6

22.9

516

3273

H02AB06

ATC

prednisolone; systemic

1.3

22.8

2224

18621

TK800

NOMESCO Finland

Hemodialysis

2.8

22.7

116

425

A12AA04

ATC

calcium carbonate; oral

3.2

22.6

281

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

27.4

22.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

22.1

290

H21.0

ICD-10 Finland

Hyphaema

6.6

22.1

137

Kela drug reimbursment

Uraemia requiring dialysis

4.6

21.9

111

C09CA06

ATC

candesartan; oral

1.4

21.7

1032

7674

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

220.9

21.6

B01AB05

ATC

enoxaparin; parenteral

1.4

21.6

1553

12384

H57.1

ICD-10 Finland

Ocular pain

2.5

21.4

141

585

H35.4

ICD-10 Finland

Peripheral retinal degeneration

43.5

21.4

SPAT1262

SPAT

Handing over of treatment supplies

1.5

21.3

871

6292

A10BH05

ATC

linagliptin; oral

1.8

21.3

308

1724

A46

ICD-10 Finland

Erysipelas

1.5

21.3

766

5396

H47.2

ICD-10 Finland

Optic atrophy

6.6

21.3

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.7

21.0

180

Z94.0

ICD-10 Finland

Kidney transplant status

4.4

21.0

119

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

20.9

1399

11013

C10AA07

ATC

rosuvastatin; oral

1.4

20.9

1444

11429

H30.2

ICD-10 Finland

Posterior cyclitis

+∞

20.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

20.8

550

3622

L04AA06

ATC

mycophenolic acid; systemic

3.2

20.7

260

C07AB02

ATC

metoprolol; systemic

1.4

20.5

1175

9015

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

20.5

557

3692

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.3

20.4

232

L04AD02

ATC

tacrolimus; systemic

4.9

20.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

20.3

734

5171

NHQ40

NOMESCO Finland

Amputation of toe

2.8

20.2

100

360

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

20.2

1067

8073

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

20.1

154

684

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

20.1

1156

8871

A10AE06

ATC

insulin degludec; parenteral

2.5

20.1

124

500

M79.6

ICD-10 Finland

Pain in limb

1.3

19.8

1740

14260

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

19.7

230

1200

N18.0

ICD-10 Finland

End-stage renal disease

3.3

19.6

223

S97

ICPC

Chronic ulcer skin

1.8

19.6

329

1927

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

19.5

1687

13780

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

19.5

122

495

CHC05

NOMESCO Finland

Iridotomy

2.8

19.5

362

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

19.3

900

6653

Z2221

NOMESCO Finland

Medical doctor

1.4

19.3

1166

9014

B05DA

ATC

Isotonic solutions

4.8

18.9

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.7

18.8

101

380

CKD50

NOMESCO Finland

Endodiathermy of retina

+∞

18.8

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

18.6

221

1160

Z49.2

ICD-10 Finland

Other dialysis

4.6

18.6

CD2S4

NOMESCO Finland

Photography of eye

4.6

18.6

L17

ICPC

Foot/toe symptom/complaint

1.4

18.6

1251

9823

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

18.6

1404

11227

1LA04, ,

NOMESCO Finland

100.4

18.6

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.9

18.5

140

H40

ICD-10 Finland

Glaucoma

3.0

18.5

268

SPAT1301

SPAT

No procedures

1.3

18.5

1509

12205

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

18.4

352

2135

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.3

18.3

111

B05DB

ATC

Hypertonic solutions

5.0

18.3

C03DA01

ATC

spironolactone; oral

1.5

18.2

666

4696

S01EB01

ATC

pilocarpine; ophthalmic

3.6

18.1

170

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

18.0

1691

13940

H40.8

ICD-10 Finland

Other glaucoma

5.0

17.8

F99

ICPC

Eye/adnexa disease other

4.0

17.8

122

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.7

17.7

B01AF02

ATC

apixaban; oral

1.4

17.6

731

5284

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

5.3

17.5

R02

ICPC

Shortness of breath/dyspnoea

1.5

17.4

620

4346

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

17.4

1265

10037

H46

ICD-10 Finland

Optic neuritis

5.1

17.4

SPAT1325

SPAT

Vaccination

1.3

17.3

1682

13911

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

6.0

17.3

H16.0

ICD-10 Finland

Corneal ulcer

2.0

17.3

182

917

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.6

17.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

17.2

252

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.2

17.2

AN1

Coronary angiography

1.5

17.2

664

4732

C10AX09

ATC

ezetimibe; oral

1.4

17.2

719

5202

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

17.1

387

R04.0

ICD-10 Finland

Epistaxis

1.6

17.1

414

2668

I50.0

ICD-10 Finland

Congestive heart failure

1.5

17.1

495

3324

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

16.8

549

3780

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

4.6

16.8

H33.4

ICD-10 Finland

Traction detachment of retina

+∞

16.7

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

+∞

16.7

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

+∞

16.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

16.6

252

1432

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.3

16.5

K85

ICPC

Elevated blood pressure

1.4

16.5

805

5982

207

Kela drug reimbursment

Chronic arrhythmias

1.4

16.5

948

7243

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

16.5

611

4318

Z71.8

ICD-10 Finland

Other specified counselling

1.3

16.4

1145

9015

H44.0

ICD-10 Finland

Purulent endophthalmitis

23.1

16.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

16.3

1393

11296

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.3

1924

16297

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

16.3

446

2957

H54.1

ICD-10 Finland

Severe visual impairment, binocular

16.7

16.0

V03AE02

ATC

sevelamer; oral

5.1

16.0

J01FF01

ATC

clindamycin; systemic

1.3

16.0

1127

8887

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

16.0

1654

13764

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

15.9

547

3805

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.4

15.8

166

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.7

15.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

15.8

774

5756

R03AC02

ATC

salbutamol; inhalant

1.3

15.7

2231

19310

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.2

15.7

124

559

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

15.7

556

3891

CKC30

NOMESCO Finland

Cryopexy of detached retina

+∞

15.6

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

3.4

15.6

163

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

6.0

15.6

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

26.3

15.6

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

15.5

486

3315

CKC60

NOMESCO Finland

Local buckling of sclera using implant

160.5

15.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.0

15.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

15.4

1877

15928

ZXE00

NOMESCO Finland

One hour or less

1.3

15.4

1645

13731

SPAT1009

SPAT

Measurement of intraocular pressure

2.7

15.3

303

F28

ICPC

Limited function/disability (F)

4.0

15.3

109

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

15.3

747

5550

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

7.0

15.2

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

15.1

111

485

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

15.1

592

4225

C08CA05

ATC

nifedipine; systemic

1.6

15.1

332

2090

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

15.1

1546

12827

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

15.0

427

2855

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

14.9

2728

24286

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.9

1614

13479

WX199

NOMESCO Finland

Other local analgesia

2.0

14.9

171

889

J01AA02

ATC

doxycycline; systemic

1.3

14.8

3533

32475

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

14.8

1607

13425

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

3.6

14.6

131

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

14.6

806

6107

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

14.6

281

1710

H53

ICD-10 Finland

Visual disturbances

4.3

14.5

H34

ICD-10 Finland

Retinal vascular occlusions

150.4

14.5

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

14.5

365

2374

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.4

1312

10701

A28

ICPC

Limited function/disability NOS

1.3

14.4

1012

7958

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

14.4

590

4246

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.3

14.3

157

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

14.3

2068

17877

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

14.2

179

960

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

14.2

600

4340

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

14.1

226

V03AE01

ATC

polystyrene sulfonate; oral

2.7

14.1

276

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.2

14.1

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

14.1

129

618

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

14.1

804

6124

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

14.0

382

2527

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

5.8

14.0

C09AA02

ATC

enalapril; systemic

1.3

14.0

1042

8262

N19

ICD-10 Finland

Unspecified kidney failure

1.8

13.9

211

1199

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.3

13.8

105

466

H05BX01

ATC

cinacalcet; oral

3.8

13.7

109

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.6

1847

15812

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.4

13.5

371

N03AX16

ATC

[U] pregabalin

1.3

13.5

995

7869

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.1

13.5

184

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

13.4

285

1777

J01MA12

ATC

levofloxacin; systemic

1.3

13.4

887

6904

V03AE03

ATC

lanthanum carbonate; oral

5.6

13.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

13.3

460

3200

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.6

13.3

285

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.3

13.3

SPAT1310

SPAT

Counselling related to known health issue

1.3

13.2

1339

11055

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.1

13.2

181

SPAT1254

SPAT

Administration of medicine

1.4

13.1

734

5567

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

13.1

263

1617

C10AA04

ATC

fluvastatin; oral

1.5

13.1

482

3395

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

13.1

613

4513

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

13.0

456

3182

K02.1

ICD-10 Finland

Caries of dentine

1.2

13.0

2100

18318

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

13.0

102

460

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.3

13.0

397

R55

ICD-10 Finland

Syncope and collapse

1.4

12.9

563

4092

CKA10

NOMESCO Finland

Biopsy of vitreous body

19.1

12.9

ZXD05

NOMESCO Finland

Urgent procedure

1.3

12.9

1314

10853

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

12.9

137

695

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

12.8

327

2134

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

12.6

1076

8675

N02AX02

ATC

tramadol; systemic, rectal

1.2

12.6

1941

16820

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

12.5

298

1912

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

12.5

228

1367

H3602, E113,

ICD-10 Finland

+∞

12.5

H44.5

ICD-10 Finland

Degenerated conditions of globe

11.0

12.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

12.5

925

7317

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

12.4

161

873

R60.0

ICD-10 Finland

Localized oedema

1.4

12.4

598

4423

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

12.4

308

1997

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

12.3

104

483

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

12.2

274

1733

M04AA01

ATC

allopurinol; systemic

1.4

12.2

732

5609

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

12.1

795

6174

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

12.1

915

7252

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

12.1

343

2291

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.4

12.0

124

Z2446

NOMESCO Finland

Social worker

1.7

12.0

241

1482

SPAT1260

SPAT

Consultation of another employee

1.3

12.0

761

5881

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

12.0

133

685

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.0

666

5043

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

12.0

235

1438

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

4.0

11.9

A04

ICPC

Weakness/tiredness general

1.4

11.9

651

4916

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.5

11.9

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

46.8

11.9

R51.80

ICD-10 Finland

Headache

1.4

11.7

499

3610

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.4

11.7

334

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

11.7

164

912

C09DA06

ATC

candesartan and diuretics; oral

1.5

11.6

332

2221

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.6

1691

14531

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.9

11.6

145

778

SPAT1097

SPAT

Recording of ECG

1.4

11.5

705

5416

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

11.5

106

511

H36.8*I70.8

ICD-10 Finland

Atherosclerotic retinopathy

+∞

11.5

CKC70

NOMESCO Finland

Circular buckling of sclera

+∞

11.5

J01DA01

ATC

[U] cefalexin

1.2

11.4

2662

24020

Z01.2

ICD-10 Finland

Dental examination

1.2

11.4

1566

13357

1BA01, ,

NOMESCO Finland

120.3

11.4

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

11.4

229

1410

F01

ICPC

Eye pain

2.1

11.4

466

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.6

11.4

239

1488

R50.9

ICD-10 Finland

Fever, unspecified

1.4

11.4

622

4695

I20.09

ICD-10 Finland

Unstable angina

1.5

11.4

315

2093

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

11.4

1396

11758

WX872

NOMESCO Finland

Intensive care

1.6

11.3

242

1514

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

11.3

745

5789

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

8.9

11.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

11.2

716

5537

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

11.1

487

3541

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.6

11.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

11.0

434

3098

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

4.6

10.9

H33.2

ICD-10 Finland

Serous retinal detachment

43.4

10.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

10.9

1982

17407

H18.1

ICD-10 Finland

Bullous keratopathy

5.4

10.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

10.8

294

1946

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.1

10.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.8

1065

8732

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

2.7

10.7

198

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

10.7

812

6429

M54.5

ICD-10 Finland

Low back pain

1.3

10.7

1327

11175

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.6

10.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.0

10.7

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

10.6

186

1104

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

10.6

753

5908

UJF32

NOMESCO Finland

Coloscopy

1.3

10.5

1204

10040

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.2

10.5

130

RS221, ,

NOMESCO Finland

2.6

10.5

223

I72.4

ICD-10 Finland

Aneurysm and dissection of artery of lower extremity

3.6

10.5

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

10.5

285

1887

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

10.5

608

4631

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.6

10.5

H35.29

ICD-10 Finland

Other proliferative retinopathy

110.3

10.4

H30.8

ICD-10 Finland

Other chorioretinal inflammations

+∞

10.4

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.2

10.4

378

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.4

10.4

106

R4110

NOMESCO Finland

Physiotherapy

1.3

10.4

1183

9861

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

10.4

762

6006

PE1AT

NOMESCO Finland

Femoral artery PTA

2.4

10.3

303

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

10.3

257

1667

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.7

10.3

189

1136

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

10.3

499

3690

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

10.3

541

4056

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.6

10.3

220

M48.0

ICD-10 Finland

Spinal stenosis

1.3

10.2

613

4689

H43.3

ICD-10 Finland

Other vitreous opacities

2.6

10.2

209

PD5AD

NOMESCO Finland

CT of aorta

2.0

10.2

106

534

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

10.2

398

2833

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.2

1653

14316

A10BK03

ATC

empagliflozin; oral

1.4

10.1

398

2840

S01FA01

ATC

atropine; ophthalmic

4.2

10.1

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

10.1

305

2066

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

3.6

10.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

10.0

263

1727

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.5

10.0

SPAT1216

SPAT

Assessment of functional ability

1.3

10.0

814

6505

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.6

10.0

206

1278

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.3

10.0

109

SFA10

NOMESCO Finland

One-surface restoration

1.2

10.0

1979

17486

CH2S4

NOMESCO Finland

Photography of iris

40.1

10.0

C07AG02

ATC

carvedilol; oral

1.5

9.9

306

2080

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

9.9

308

2097

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

9.9

661

5136

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.9

1156

9658

CFW99

NOMESCO Finland

Other operation on conjunctiva

5.1

9.8

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.0

9.8

136

FXZ00

NOMESCO Finland

Off-pump cardiac operation

2.9

9.7

147

WX213

NOMESCO Finland

Lower leg blockade

3.0

9.7

142

XF404

NOMESCO Finland

Ambulatory ECG

1.4

9.7

412

2979

G04CB01

ATC

finasteride; oral

1.3

9.7

648

5037

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

9.7

156

906

U02

ICPC

Urinary frequency/urgency

1.4

9.7

560

4262

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

9.6

577

4413

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

9.6

214

1353

C09CA03

ATC

valsartan; oral

1.4

9.6

427

3112

TK810

NOMESCO Finland

Hemofiltration

3.3

9.6

107

G04CA02

ATC

tamsulosin; oral

1.2

9.5

1301

11051

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

9.5

223

1428

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

9.5

635

4936

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.1

9.4

414

3623C

ICD-9 Finland

Other retinal disorders, Retinal vascular occlusion[OCCLUSIO VENAE CENTRALIS RETINAE]

+∞

9.4

H3602, E103,

ICD-10 Finland

+∞

9.4

37703

ICD-8 Finland

Other diseases of retina and optic nerve, Thrombosis venae centralis retinae

+∞

9.4

H3603, E107,

ICD-10 Finland

+∞

9.4

ZX199

NOMESCO Finland

Other rote

12.3

9.3

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

21.7

9.3

XKD00

NOMESCO Finland

Uroflowmetry

1.3

9.3

834

6740

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

9.3

280

C09DA01

ATC

losartan and diuretics; oral

1.4

9.3

487

3647

SPAT1312

SPAT

General health counselling

1.2

9.3

1238

10481

N06AX11

ATC

mirtazapine; oral

1.2

9.3

1369

11716

A29

ICPC

General symptom/complaint other

1.3

9.3

560

4287

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.3

9.3

104

SPAT1153

SPAT

Removal of sutures

1.2

9.3

1419

12192

A10BB12

ATC

glimepiride; oral

1.4

9.3

366

2612

XCX10

NOMESCO Finland

Other photography of eye

9.5

9.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

9.2

122

668

A02BC05

ATC

esomeprazole; systemic

1.2

9.2

1701

14897

A10BK01

ATC

dapagliflozin; oral

1.5

9.2

284

1934

A11

ICPC

Chest pain NOS

1.4

9.2

357

2542

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.2

2361

21327

E66.8

ICD-10 Finland

Other obesity

1.8

9.1

137

780

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

4.8

9.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.4

9.0

241

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

3.3

9.0

CHD35

NOMESCO Finland

Laser goniopuncture

3.3

9.0

101

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

9.0

347

2466

P20

ICPC

Memory disturbance

1.3

9.0

789

6360

H01.0

ICD-10 Finland

Blepharitis

1.6

9.0

190

1187

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

9.0

323

2266

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

8.9

335

2371

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

4.9

8.8

Z00.0

ICD-10 Finland

General medical examination

1.3

8.8

782

6311

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

8.8

284

1950

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.8

1312

11232

R05

ICPC

Cough

1.3

8.8

890

7299

ZX120

NOMESCO Finland

Intravenous

1.4

8.8

393

2868

ZXD20

NOMESCO Finland

Day surgery

1.4

8.7

475

3579

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

8.7

488

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

8.7

362

2608

J01CF05

ATC

flucloxacillin; systemic

1.6

8.7

216

1404

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.7

8.7

170

1043

UDC00

NOMESCO Finland

Ear microscopy

1.5

8.6

294

2042

TK820

NOMESCO Finland

Peritoneal dialysis

3.9

8.6

A10BH01

ATC

sitagliptin; oral

1.4

8.6

435

3241

H44.1

ICD-10 Finland

Other endophthalmitis

11.6

8.6

RS222, ,

NOMESCO Finland

2.5

8.5

217

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

2.7

8.5

159

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.0

8.5

438

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

8.5

100

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

8.4

203

1309

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

8.4

345

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

90.2

8.4

M31.6

ICD-10 Finland

Other giant cell arteritis

3.9

8.4

SPAT1229

SPAT

Assessment of need for aid

1.4

8.4

387

2839

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.4

811

6614

B01AC07

ATC

dipyridamole; systemic

1.5

8.4

270

1855

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.5

8.4

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

8.3

C08CA10

ATC

nilvadipine; oral

1.9

8.3

518

WZC30

NOMESCO Finland

Teaching

1.3

8.3

620

4891

C03AA03

ATC

hydrochlorothiazide; oral

1.4

8.3

462

3494

WX892

NOMESCO Finland

Monitored bed care

1.4

8.3

332

2377

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.6

8.3

167

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

8.3

136

796

E0000UV, ,

ATC

1.2

8.3

1637

14393

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.1

8.2

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.2

802

6545

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

8.2

931

7732

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.3

8.2

474

3605

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

8.2

188

1200

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.2

426

3189

M10.9

ICD-10 Finland

Gout, unspecified

1.4

8.2

341

2460

SPAT1053

SPAT

Memory test

1.3

8.1

844

6938

J45

ICD-10 Finland

Asthma

1.4

8.1

345

2496

L04AX01

ATC

azathioprine; systemic

1.7

8.1

139

823

C10AA03

ATC

pravastatin; oral

1.4

8.1

360

2625

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

8.1

614

4854

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

8.1

481

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

17.2

8.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.7

8.1

138

817

A02BC03

ATC

lansoprazole; oral

1.2

8.0

1258

10808

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.0

8.0

379

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

8.0

676

5419

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

8.0

209

1374

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

4.1

8.0

E87.5

ICD-10 Finland

Hyperkalaemia

1.9

8.0

490

K77

ICPC

Heart failure

1.7

8.0

129

752

S01FA04

ATC

cyclopentolate; ophthalmic

2.5

8.0

194

SPAT1255

SPAT

Intravenous administration of medicine

1.4

7.9

300

2125

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

7.9

120

686

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

7.9

173

1091

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

7.9

696

5611

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.6

7.9

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

7.9

228

1533

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

7.7

7.9

S21

ICPC

Skin texture symptom/complaint

1.3

7.8

581

4580

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

7.8

1392

12110

A03

ICPC

Fever

1.3

7.7

464

3550

F94

ICPC

Blindness

45.0

7.7

XF402

NOMESCO Finland

ECG with work load test

1.3

7.7

476

3656

A10AD05

ATC

insulin aspart; parenteral

2.0

7.7

426

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

7.7

173

1099

280

Kela drug reimbursment

Clopidogrel

1.9

7.7

447

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.6

2638

24287

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

3.3

7.6

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

7.6

259

1798

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

7.6

161

1007

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.6

1365

11873

S01BA01

ATC

dexamethasone; ophthalmic

1.7

7.6

132

786

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.7

7.6

146

S29

ICPC

Skin symptom/complaint other

1.3

7.5

773

6342

J01FA06

ATC

roxithromycin; oral

1.2

7.5

1601

14140

WX290

NOMESCO Finland

Other blockage of nerve

1.2

7.5

1383

12057

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

7.5

115

662

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

7.4

184

1196

CD1AE

NOMESCO Finland

Other special ultrasound examination of the eye

80.2

7.4

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.4

7.4

201

Angiography of the heart and coronary arteries

1.4

7.4

356

2632

H33

ICD-10 Finland

Retinal detachments and breaks

13.4

7.4

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

7.6

7.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

7.4

229

1563

K90

ICPC

Stroke/cerebrovascular accident

1.6

7.4

153

954

SFA30

NOMESCO Finland

Three-surface restoration

1.2

7.3

1501

13204

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

7.3

212

1425

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

7.3

391

2937

I20.01

ICD-10 Finland

Unstable angina

1.6

7.3

157

986

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

7.3

113

651

H35.20

ICD-10 Finland

Proliferative vitreoretinopathy

+∞

7.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

7.3

301

2168

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.6

7.3

149

L04AD01

ATC

ciclosporin; systemic

2.2

7.3

253

L03

ICPC

Low back symptom/complaint

1.2

7.3

987

8348

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

7.3

250

1741

S01BA07

ATC

fluorometholone; ophthalmic

2.2

7.3

279

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.2

760

6250

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

7.2

1187

10228

-50

ICPC

Medication/prescr/renewal

1.6

7.2

181

1179

H54.7

ICD-10 Finland

Unspecified visual loss

3.2

7.2

UKC02

NOMESCO Finland

Cystoscopy

1.2

7.2

815

6756

H26.3

ICD-10 Finland

Drug-induced cataract

3.4

7.2

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.7

7.2

138

S01.0

ICD-10 Finland

Open wound of scalp

1.4

7.2

346

2556

SFA20

NOMESCO Finland

Two-surface restoration

1.2

7.2

2005

18103

H02.3

ICD-10 Finland

Blepharochalasis

1.4

7.2

265

1870

-1, ,

NOMESCO Finland

1.2

7.2

1067

9106

A10AB06

ATC

insulin glulisine; parenteral

2.7

7.1

139

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

20.0

7.1

J20

ICD-10 Finland

Acute bronchitis

1.4

7.1

351

2605

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

7.1

110

634

R31

ICD-10 Finland

Unspecified haematuria

1.3

7.1

507

3974

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

7.1

349

2589

R52.9

ICD-10 Finland

Pain, unspecified

1.4

7.1

356

2650

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

2.4

7.1

187

A10AD04

ATC

insulin lispro; parenteral

4.1

7.1

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

7.1

371

2781

D06

ICPC

Abdominal pain localized other

1.4

7.1

285

2045

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

7.0

344

2549

H02AB04

ATC

methylprednisolone; systemic

1.3

7.0

564

4489

H16.9

ICD-10 Finland

Keratitis, unspecified

2.2

7.0

264

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

7.0

168

1086

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

7.0

1621

14410

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

6.9

145

906

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.8

6.9

521

R06AE07

ATC

cetirizine; oral

1.2

6.9

1569

13911

D68.8

ICD-10 Finland

Other specified coagulation defects

2.6

6.9

147

S01BA04

ATC

prednisolone; ophthalmic

1.8

6.9

500

A10AD01

ATC

insulin (human); parenteral

2.1

6.9

285

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

5.4

6.9

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.4

6.9

Z3226

NOMESCO Finland

Physiotherapist

1.2

6.9

743

6130

K65.0

ICD-10 Finland

Acute peritonitis

2.2

6.9

240

C09CA07

ATC

telmisartan; oral

1.4

6.8

302

2202

M10.0

ICD-10 Finland

Idiopathic gout

1.6

6.8

166

1076

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.1

6.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.8

1298

11339

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

6.8

104

599

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.7

655

5337

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

6.7

117

697

H47.3

ICD-10 Finland

Other disorders of optic disc

5.6

6.7

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.7

898

7576

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

6.7

378

2864

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.8

6.7

505

OAB50, ,

SPAT

1.5

6.7

202

1373

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

6.7

282

2041

SPAT1281

SPAT

Other administrative function

1.4

6.7

297

2169

D07AC01

ATC

betamethasone; topical

1.2

6.6

1442

12731

S01AX11

ATC

[U] ofloxacin

1.6

6.6

142

893

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

6.6

162

1051

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.6

6.6

133

-44

ICPC

Preventive immunization/medic

1.3

6.6

367

2775

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

2.3

6.6

212

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.6

1466

12967

F03

ICPC

Eye discharge

1.5

6.6

200

1360

A99

ICPC

Disease/condition unspecnature/site

1.3

6.6

366

2769

K87

ICPC

Hypertension complicated

1.7

6.6

126

771

A01

ICPC

Pain general/multiple sites

1.4

6.6

355

2674

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

6.6

193

1304

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

6.5

325

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.3

6.5

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.6

6.5

159

1031

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

3.8

6.5

H26.02

ICD-10 Finland

Presenil cataract

1.9

6.5

438

H02AB07

ATC

prednisone; oral

1.3

6.4

567

4567

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.7

6.4

118

QDB10, ,

SPAT

1.9

6.4

383

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

6.4

260

1868

3AC01, ,

NOMESCO Finland

2.5

6.4

159

K99

ICPC

Cardiovascular disease other

1.6

6.4

131

815

RS220, ,

NOMESCO Finland

2.3

6.4

196

H65.2

ICD-10 Finland

Chronic serous otitis media

2.2

6.4

215

A02BC01

ATC

omeprazole; systemic

1.2

6.4

1212

10569

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

6.4

223

1559

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

14.3

6.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

6.4

505

4015

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.1

6.4

268

K03.66

ICD-10 Finland

Tooth plaque

1.4

6.3

254

1822

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.5

6.3

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

8.1

6.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.3

979

8380

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.1

6.3

269

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

6.3

146

937

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

6.3

109

650

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

5.5

6.3

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

2.4

6.3

179

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.2

6.3

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

1.8

6.3

436

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.3

953

8142

H54

ICD-10 Finland

Visual impairment including blindness (binocular or monocular)

18.0

6.3

H3603, E106,

ICD-10 Finland

+∞

6.2

H35.1

ICD-10 Finland

Retinopathy of prematurity

+∞

6.2

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

+∞

6.2

H3601, E116,

ICD-10 Finland

+∞

6.2

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

+∞

6.2

H3601, E119,

ICD-10 Finland

+∞

6.2

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

+∞

6.2

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

+∞

6.2

H3601, E1100,

ICD-10 Finland

+∞

6.2

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

6.2

279

2039

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

6.2

414

3214

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

6.2

1120

9719

A10BB01

ATC

glibenclamide; oral

1.5

6.2

208

1443

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.6

6.2

144

924

J01FA09

ATC

clarithromycin; systemic

1.2

6.2

1046

9023

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

6.2

415

3226

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.0

6.2

305

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.2

403

3122

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.1

6.2

258

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.0

6.1

285

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.2

6.1

219

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

6.1

200

1381

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.5

6.1

161

1064

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.4

6.1

163

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

6.1

154

1008

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

6.1

683

5656

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

6.1

103

611

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.0

6.1

307

AN4

Balloon angioplasty and drug eluding stent

1.5

6.1

160

1058

R01AD09

ATC

mometasone; nasal

1.2

6.1

1522

13583

C08DB01

ATC

diltiazem; oral

1.4

6.0

280

2060

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

6.0

916

7824

W19

ICD-10 Finland

Unspecified fall

1.3

6.0

396

3072

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

3002

22159

1.87

98.33

23.6

19.1

1.35

1.37

inr

0.49

828

6157

(3013826) Glucose [Moles/volume] in Serum or Plasma

3308

25405

1.87

92.95

6.3

4.7

6.94

6.81

mmol/l

2.76

3146

23885

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2039

13601

1.83

90.14

2.4

2.2

201.67

223.95

u/l

0.50

1923

12630

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1181

7061

1.88

70.89

2.2

2.0

30.19

30.14

0.11

1158

6829

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4225

36484

1.94

66.60

7.6

6.3

42.01

40.51

mmol/mol

18.10

3857

32964

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2083

14945

1.67

64.75

3.6

3.2

2347.88

1779.04

ng/l

4.39

1822

13007

(3013707) Erythrocyte sedimentation rate by Westergren method

3582

29580

1.72

63.97

4.8

4.2

15.81

14.28

mm/h

5.68

3286

26927

(3023103) Potassium [Moles/volume] in Serum or Plasma

4592

41091

2.23

62.03

27.9

20.5

4.00

mmol/l

0.32

4482

39887

(3019550) Sodium [Moles/volume] in Serum or Plasma

4586

41025

2.22

61.85

27.6

20.3

139.33

139.60

mmol/l

8.04

4485

39879

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4407

38953

1.99

59.79

22.9

17.1

25.42

27.03

mg/l

2.51

3798

31824

(3013115) Eosinophils [#/volume] in Blood

2644

20485

1.61

58.02

6.6

5.7

0.20

e9/l

1.16

2300

17603

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2851

22549

1.60

56.91

9.2

6.6

1.21

mmol/l

2.38

2410

18996

(3006315) Basophils [#/volume] in Blood

2564

19830

1.59

55.83

6.4

5.5

0.04

e9/l

0.35

2222

16824

(3037467) Urinalysis macro (dipstick) panel - Urine

3433

28478

1.63

55.55

5.6

4.7

—

(3001604) Monocytes [#/volume] in Blood

2554

19761

1.59

55.31

6.4

5.5

0.63

0.62

e9/l

0.75

2209

16753

(3020682) Albumin/Creatinine [Ratio] in Urine

1927

13962

1.61

55.00

4.3

3.7

13.45

8.59

mg/mmol

4.07

1292

8760

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2321

17579

1.59

54.94

5.1

4.1

118.75

79.59

ng/l

0.40

1867

13488

(40760892) CBC W Ordered Manual Differential panel - Blood

2417

18535

1.58

53.85

7.0

6.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4246

37411

1.82

53.45

5.3

4.7

4.21

4.48

mmol/l

54.87

3879

33795

(3031040) Bacteria [#/volume] in Urine by Automated count

3377

28026

1.61

53.30

5.8

5.1

1145.85

1628.82

e6/l

0.36

473

(3019198) Lymphocytes [#/volume] in Blood

2592

20229

1.57

53.29

6.6

5.6

1.78

1.87

e9/l

1.65

2275

17519

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4105

35828

1.76

53.19

4.8

4.1

1.29

1.28

mmol/l

0.42

3674

31768

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4339

38508

1.87

53.03

6.0

5.3

2.37

2.60

mmol/l

53.99

3953

34608

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4068

35440

1.74

52.74

5.2

4.7

2.62

2.12

mu/l

0.45

3650

31663

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4208

37052

1.79

52.08

5.3

4.6

1.38

1.44

mmol/l

18.22

3809

33211

(3006504) Eosinophils/100 leukocytes in Blood

2416

18637

1.57

51.68

6.6

5.8

2.94

2.85

0.95

2242

17187

(3012516) Albumin [Mass/volume] in Urine

1821

13170

1.60

51.46

3.8

3.1

402.04

340.39

mg/l

0.24

1238

8386

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4540

40984

2.02

51.44

26.9

20.3

90.86

82.83

umol/l

19.32

4540

40973

(3019069) Monocytes/100 leukocytes in Blood

2423

18726

1.56

51.24

6.9

6.1

8.99

8.90

0.70

2254

17292

(3000963) Hemoglobin [Mass/volume] in Blood

4638

42223

2.14

50.86

33.3

25.2

131.41

133.04

g/l

9.69

4559

41387

(3009542) Hematocrit [Volume Fraction] of Blood

4635

42188

2.13

50.81

33.3

25.1

38.88

39.41

5.24

4280

38702

(3018010) Neutrophils/100 leukocytes in Blood

2422

18739

1.56

50.81

6.6

5.7

59.51

58.48

3.88

2252

17329

(3010813) Leukocytes [#/volume] in Blood

4637

42219

2.13

50.70

33.0

25.0

7.01

6.90

e9/l

2.25

4488

40679

(3009508) Creatinine [Moles/volume] in Urine

1845

13427

1.59

50.54

3.7

3.0

6.67

7.27

mmol/l

8.76

1531

11052

(3035941) MCH [Entitic mass]

4636

42215

2.13

50.53

32.9

24.9

30.42

30.44

0.32

4553

41363

(3024731) MCV [Entitic volume]

4636

42215

2.13

50.53

33.0

25.0

91.72

91.70

0.14

4553

41365

(3026361) Erythrocytes [#/volume] in Blood

4636

42217

2.13

50.49

33.1

25.0

4.36

4.40

e12/l

5.87

4491

40684

(3007461) Platelets [#/volume] in Blood

4635

42208

2.12

50.42

33.1

25.0

237.48

241.44

e9/l

3.91

4517

40846

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3741

32013

1.64

50.33

8.8

7.6

80.55

80.65

u/l

0.04

3506

29964

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

153

407

3.84

50.19

1.0

1.2

120.03

113.35

1.61

141

362

(3022096) Basophils/100 leukocytes in Blood

2347

18087

1.55

49.73

6.6

5.8

0.66

0.65

0.14

2172

16663

(3002030) Lymphocytes/100 leukocytes in Blood

2450

19066

1.55

49.65

6.8

6.0

24.98

26.21

5.95

2277

17645

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4527

40951

1.97

49.08

13.4

11.1

24.31

25.21

u/l

1.28

4346

39088

(3036489) Thrombin time

328

1379

2.47

48.41

2.1

1.9

22.09

21.68

0.21

271

1254

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2417

18884

1.53

47.21

2.3

2.1

93.10

93.07

pmol/l

0.01

1298

9807

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

156

440

3.63

47.01

1.3

1.2

3.10

5.45

u/ml

1.83

195

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

161

464

3.55

46.97

1.2

2.54

4.02

u/ml

0.62

151

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2584

20499

1.53

46.90

8.1

5.9

1.21

mmol/l

2.14

2330

18496

(3013650) Neutrophils [#/volume] in Blood by Automated count

2857

23212

1.53

46.01

9.4

8.7

4.40

4.29

e9/l

1.64

2516

19992

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

151

425

3.63

45.64

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1619

11641

1.57

45.58

2.6

2.3

3.10

3.08

mg/l

0.12

1388

9800

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4262

38038

1.75

45.55

5.6

5.0

6.21

6.05

mmol/l

10.23

3792

33805

(40761511) CBC panel - Blood by Automated count

4398

39617

1.82

45.44

21.5

16.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2450

19379

1.51

43.98

5.9

4.7

34.47

34.63

g/l

0.71

2254

17823

(3023368) Bacteria identified in Blood by Culture

1796

13317

1.54

43.61

5.0

4.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2741

22291

1.50

42.34

6.4

6.2

11.87

12.24

umol/l

0.85

2588

21114

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

260

1051

2.55

41.64

2.2

2.1

96.12

88.50

6.61

253

1016

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2067

15937

1.50

41.01

3.7

2.8

143.68

157.43

ug/l

2.01

1878

14382

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3382

28915

1.51

39.49

4.2

3.9

15.24

15.06

pmol/l

3.54

2987

25685

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1151

7919

1.59

37.96

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4073

36384

1.60

37.89

21.5

16.3

69.77

73.44

ml/min/173m2

21.46

3443

30164

(3003458) Phosphate [Moles/volume] in Serum or Plasma

903

5895

1.65

36.83

9.1

5.3

1.07

1.03

mmol/l

3.89

838

5393

(3004789) Transferrin [Mass/volume] in Serum or Plasma

996

6677

1.61

36.45

3.5

2.5

2.23

2.26

g/l

1.12

932

6102

(3020779) Urea [Moles/volume] in Serum or Plasma

692

4225

1.74

36.23

10.9

6.4

12.19

11.02

mmol/l

3.75

664

3974

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

949

6315

1.62

35.72

3.7

2.5

20.20

21.71

3.13

813

5313

(3026008) Bacteria identified in Urine by Culture

1885

14553

1.47

35.68

3.8

3.5

—

(3033658) Prothrombin time (PT) actual/Normal

1442

10574

1.51

35.16

5.2

4.0

83.70

84.78

0.78

1411

10316

(3022948) Iron [Moles/volume] in Serum or Plasma

1053

7213

1.58

35.01

3.5

2.5

11.10

12.16

umol/l

5.90

984

6632

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

149

5.03

34.71

1.1

1.2

1.11

1.08

ratio

0.33

(3002032) Base excess in Venous blood by calculation

714

4451

1.70

34.55

5.6

3.5

1.79

1.95

mmol/l

0.58

603

3731

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1736

13309

1.46

33.52

2.8

2.5

57.92

66.30

u/l

0.75

1602

12215

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2091

16625

1.44

33.14

2.5

2.2

80.17

79.16

nmol/l

0.87

1824

14502

(3021447) Carbon dioxide [Partial pressure] in Venous blood

710

4466

1.69

33.13

5.5

3.5

5.86

5.83

kpa

0.21

691

4321

(3012544) pH of Venous blood

730

4627

1.67

33.09

5.5

3.5

7.37

7.38

—

(3018095) Leukocytes [#/volume] in Urine

1962

15424

1.44

33.03

4.8

3.9

79.62

117.50

e6/l

1.98

1496

11246

(3026493) Urate [Moles/volume] in Serum or Plasma

1491

11138

1.48

32.70

3.3

2.8

6251.60

5739.41

umol/l

0.15

1291

9455

(3035350) Ketones [Presence] in Urine by Test strip

2418

19848

1.42

31.53

4.8

4.1

0.00

estimate

1.98

518

3985

(3000991) Gas panel - Venous blood

632

3904

1.71

31.45

9.7

7.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2435

20050

1.41

30.98

4.9

4.1

0.00

estimate

0.80

456

3574

(3027945) Reticulocytes/100 erythrocytes in Blood

857

5741

1.59

30.92

2.6

2.4

1.84

1.78

0.98

757

4999

(3021960) Folate [Moles/volume] in Serum or Plasma

1486

11208

1.46

30.60

1.7

1.6

19.57

20.15

nmol/l

0.64

1248

9487

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2347

19256

1.41

30.19

3.1

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

2395

19795

1.40

29.11

6.4

5.4

0.00

estimate

0.50

476

3655

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1234

9052

1.48

29.04

5.2

4.1

322.57

481.78

ng/l

0.69

1054

7775

(3002582) Erythrocytes [#/volume] in Urine

1743

13650

1.42

28.90

4.2

3.5

93.13

84.10

e6/l

0.10

1411

10591

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2729

23077

1.39

28.84

3.5

3.1

53.00

55.27

u/l

0.63

2470

20885

(3044640) Blood type and Crossmatch panel - Blood

1736

13593

1.42

28.78

3.1

2.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

220

981

2.30

28.36

2.7

2.4

183.28

203.91

2.98

210

929

(3044889) 12 lead EKG panel

3268

28581

1.40

27.73

4.9

4.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

5.45

27.37

1.0

99.55

89.76

1.26

(3019309) Folate [Moles/volume] in Red Blood Cells

1319

9895

1.45

27.36

1.9

1.8

1166.46

1166.39

nmol/l

0.00

992

7371

(3021589) Normoblasts [#/volume] in Blood

2117

17264

1.39

27.24

12.4

10.2

0.00

e9/l

0.32

1762

13990

(3003396) Base excess in Arterial blood by calculation

824

5633

1.55

26.87

7.0

6.5

0.91

1.16

mmol/l

0.82

646

4417

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

681

4456

1.61

26.81

2.8

2.4

6.66

6.97

ug/l

0.13

583

3791

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

415

2378

1.81

26.67

1.8

1.7

1.56

1.58

g/l

0.09

352

2017

(3009445) Proteinase 3 Ab [Units/volume] in Serum

334

1800

1.92

26.04

1.3

1.5

4.16

14.72

u/ml

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1006

7218

1.49

26.04

3.7

3.0

0.82

0.81

mmol/l

0.26

955

6669

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1363

10377

1.43

25.83

2.9

2.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1156

8552

1.46

25.53

1.8

1.7

1.44

1.50

mg/l

0.18

909

6666

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

798

5481

1.54

25.35

3.9

4.1

246.11

245.38

u/l

0.05

749

5123

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

796

5495

1.53

24.65

1.9

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1865

15077

1.37

24.53

3.6

3.3

2.35

mmol/l

1.26

1605

12960

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

797

5514

1.53

24.41

1.9

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

624

4095

1.60

24.12

2.7

2.6

66.36

66.00

g/l

0.56

564

3638

(3027801) Oxygen [Partial pressure] in Arterial blood

811

5653

1.52

23.94

7.1

6.5

11.78

11.98

kpa

0.51

769

5368

(3024354) Oxygen [Partial pressure] in Venous blood

571

3675

1.62

23.91

4.4

3.0

4.64

4.46

kpa

0.77

553

3545

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

811

5655

1.52

23.90

7.1

6.5

5.01

5.07

kpa

1.09

766

5377

(3015736) pH of Urine

1954

15964

1.36

23.86

4.5

3.8

5.72

5.81

0.36

660

(3002173) Hemoglobin [Mass/volume] in Arterial blood

685

4605

1.56

23.85

7.6

7.2

118.18

120.25

g/l

1.89

671

4479

(3042936) Bacteria identified in Isolate by Culture

868

6142

1.50

23.83

2.4

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

721

4908

1.55

23.74

2.1

1.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

300

3.17

23.45

2.4

2.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1538

12142

1.38

23.07

3.3

3.2

31.66

37.51

u/l

2.44

1442

11401

(3016502) Oxygen saturation in Arterial blood

736

5072

1.53

22.84

7.3

6.7

95.19

95.37

0.33

713

4867

(3018418) pH of Serum or Plasma

1670

13399

1.37

22.53

5.8

4.0

7.40

0.42

302

2520

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

160

3.97

22.19

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

3602

32503

1.37

22.07

27.2

20.1

15.44

15.42

0.09

3547

31824

(3013512) EKG study

1657

13314

1.36

22.03

5.0

4.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

535

3459

1.61

21.91

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

619

4145

1.56

21.82

8.0

6.2

1.36

1.39

mmol/l

0.30

603

4023

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

543

3530

1.60

21.73

5.8

3.5

121.49

95.61

ng/l

5.31

467

2968

(3023520) Reticulocytes [#/volume] in Blood

647

4385

1.54

21.60

2.5

70.63

68.05

e9/l

0.95

500

3315

(3030467) Casts [#/volume] in Urine by Automated count

1557

12473

1.36

20.84

4.0

3.4

0.42

0.51

e6/l

1.22

1255

9625

(36304419) Bacteria [Presence] in Urine

1498

11932

1.36

20.79

4.0

3.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2215

18711

1.33

20.64

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1838

15121

1.34

20.54

5.2

4.4

—

(3000850) Epithelial cells [#/volume] in Urine

1241

9618

1.38

20.35

3.2

2.7

4.89

5.02

e6/l

0.13

1118

8603

(3037522) Nuclear Ab [Titer] in Serum

658

4531

1.52

20.34

1.3

749.01

497.76

titre

1.80

142

993

(3004119) Hemoglobin [Mass/volume] in Venous blood

463

2950

1.63

20.07

4.4

3.1

123.65

127.34

g/l

2.93

455

2866

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

359

2157

1.71

19.48

7.0

3.6

23.96

24.16

mmol/l

0.56

353

2101

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

255

1386

1.88

19.36

1.5

1.6

164.44

269.44

titre

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

289

1635

1.81

19.31

2.1

2.2

574.98

673.43

ug/l

0.18

273

1543

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

522

3456

1.57

19.24

1.9

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

103

4.50

19.12

1.2

1.1

5.00

6.15

u/ml

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

657

4599

1.49

18.68

3.4

3.0

264.45

232.81

ng/l

0.90

617

4213

(3026782) Osmolality of Urine

1188

9252

1.37

18.65

3.7

3.0

516.10

545.86

mosm/kgh2o

5.86

1032

7910

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

217

1133

1.96

18.60

1.7

1.5

3.92

19.62

iu/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

267

1521

1.80

17.45

1.9

1.7

38.90

37.87

u/l

0.36

221

1288

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

358

2218

1.66

17.30

3.7

2.5

0.66

0.65

0.06

358

2206

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

363

2264

1.65

17.09

3.7

2.5

1.19

1.17

0.17

363

2250

(3029937) Albumin [Presence] in Urine by Test strip

1364

10975

1.33

17.01

5.3

4.5

0.00

estimate

0.44

451

3463

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

239

3.04

16.91

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

204

1081

1.92

16.76

2.6

2.3

3.66

3.59

g/l

0.26

196

1023

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

409

2643

1.60

16.67

8.0

6.8

24.40

24.89

mmol/l

1.72

402

2621

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

249

2.96

16.36

2.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

380

2428

1.61

16.23

4.2

3.3

25.11

25.18

mmol/l

0.15

367

2356

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

216

1180

1.87

16.18

1.4

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.46

16.09

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

994

7683

1.37

16.04

3.5

3.0

1.17

1.24

e6/l

0.23

623

4476

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

423

2798

1.56

15.58

1.6

1.5

—

(40758558) Short blood count panel - Blood

1268

10215

1.32

15.41

7.7

6.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

495

3406

1.50

15.18

2.1

2.2

387.85

376.46

nmol/l

0.47

445

3084

(3030981) Hyaline casts [#/volume] in Urine by Automated count

382

2484

1.58

15.15

3.6

2.9

0.18

0.32

e6/l

2.86

377

2443

(3011397) Hemoglobin [Presence] in Urine by Test strip

1207

9679

1.32

15.11

4.6

4.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

297

1823

1.67

14.88

3.6

2.8

0.33

0.35

u/ml

0.32

186

1042

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

930

7197

1.36

14.76

3.9

3.2

2.15

2.35

e6/l

0.34

569

4023

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1231

9932

1.32

14.69

1.8

1.7

53822727.98

23207392.10

pmol/l

0.67

968

8045

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

190

1031

1.88

14.56

1.4

1.5

1.16

1.17

g/l

0.11

181

962

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

386

2544

1.56

14.43

9.4

8.3

24.04

24.35

mmol/l

0.93

365

2438

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

442

3009

1.51

14.25

1.8

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

185

1003

1.88

14.22

1.4

1.5

0.24

g/l

0.30

177

940

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.31

14.17

15.3

12.9

6.51

5.26

mmol/l

0.42

(40768446) Kidney Pathology biopsy report

117

3.70

13.86

2.0

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

456

3146

1.49

13.77

6.2

6.4

24.45

24.63

mmol/l

0.44

436

2999

(3005719) IgG [Mass/volume] in Serum or Plasma

405

2731

1.52

13.65

2.6

2.7

10.53

10.51

g/l

0.03

373

2461

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

420

2855

1.51

13.63

4.3

3.6

1.66

1.98

mmol/l

0.87

323

2094

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.65

13.51

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1244

10157

1.30

13.40

4.6

3.8

—

(3003338) MCHC [Mass/volume]

3370

30944

1.26

13.40

30.5

22.5

330.90

331.41

g/l

2.44

3335

30588

(3019150) Specific gravity of Urine by Refractometry

1112

8945

1.31

13.38

5.3

4.6

1.02

kg/l

0.04

179

1388

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

436

3006

1.49

13.21

4.4

3.7

5.10

5.15

kpa

0.64

412

2814

(3009343) pH of Capillary blood

430

2959

1.50

13.15

4.4

3.7

7.42

0.13

371

(3024928) Oxygen saturation in Venous blood

173

944

1.86

13.06

4.4

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.51

13.04

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

472

3353

1.45

12.26

1.9

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.18

12.22

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1079

8757

1.29

11.97

3.2

3.1

2.46

mmol/l

0.18

945

7596

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

337

2250

1.53

11.89

5.0

4.0

48.35

47.68

0.20

330

2220

(3014148) Varicella zoster virus Ab [Titer] in Serum

238

2.67

11.79

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

178

1014

1.78

11.72

1.6

1.5

0.69

14.08

iu/ml

1.17

238

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.70

11.46

5.9

5.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

1962

1.56

11.41

2.4

2.3

3.85

3.67

g/l

1.08

270

1732

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

1965

1.55

11.34

2.4

2.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

720

1.91

11.32

7.4

4.3

747.78

2793.86

iu/ml

0.45

103

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

282

1830

1.57

11.30

2.5

2.4

3.03

2.97

g/l

0.36

252

1599

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1924

16800

1.23

11.28

5.4

3.34

4.07

ug/l

0.57

1711

14875

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

1968

1.55

11.26

2.4

2.3

7.49

7.51

g/l

0.07

270

1732

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

343

2327

1.51

11.23

2.4

23.75

24.01

au/ml

0.01

124

(3019060) Gas panel - Arterial blood

466

3365

1.42

11.06

4.2

4.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

376

2608

1.48

11.05

9.4

8.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.65

10.93

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

240

1516

1.61

10.79

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

747

5844

1.33

10.74

1.3

45.94

39.42

iu/ml

0.44

232

1805

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

310

2090

1.51

10.47

1.2

1.3

80.61

62.40

au/ml

0.35

115

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

619

4728

1.35

10.46

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

788

6234

1.31

10.45

1.5

2.63

2.65

g/l

0.11

454

3514

(46235355) HIV 1 and 2 tests - Meaningful Use set

515

3826

1.39

10.36

1.9

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

117

608

1.95

10.32

1.6

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

176

1042

1.71

10.17

4.2

2.5

2.08

1.70

mg/l

4.55

160

928

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

281

1869

1.53

10.11

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

256

1670

1.56

10.06

2.6

2.4

0.75

1.01

g/l

0.68

218

1403

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

259

1696

1.56

10.01

3.0

3.3

45.08

53.42

mg/l

0.43

209

1375

(3034860) Kappa light chains.free [Mass/volume] in Serum

259

1699

1.55

9.93

3.0

3.3

55.99

95.74

mg/l

0.62

208

1381

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1831

1.53

9.86

2.4

2.3

10.66

10.12

g/l

1.30

242

1586

(3018405) Lactate [Moles/volume] in Arterial blood

265

1751

1.54

9.84

3.6

3.7

1.39

1.40

mmol/l

0.04

260

1721

(3025941) Bacteria identified in Stool by Culture

292

1973

1.51

9.77

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

280

2.38

9.77

1.1

—

(3022313) Gas panel - Capillary blood

311

2129

1.49

9.77

4.4

3.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

424

3078

1.41

9.76

2.0

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

253

1658

1.55

9.75

3.0

3.2

3.26

3.36

ratio

0.02

122

(3003181) Sodium [Moles/volume] in Urine

151

867

1.76

9.74

1.5

1.3

62.56

62.52

mmol/l

0.00

121

682

(3028026) IgM [Mass/volume] in Serum or Plasma

315

2168

1.48

9.64

2.1

1.9

1.52

1.40

g/l

0.26

293

1930

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

172

1029

1.70

9.59

2.4

2.1

156.54

104.79

ug/min

0.69

587

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

527

1.97

9.54

1.7

1.3

113.50

119.19

u/ml

0.23

112

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1209

10192

1.24

9.48

1.8

1.6

1.36

1.33

mmol/l

0.57

1018

8428

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

295

2018

1.49

9.31

2.0

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

139

792

1.78

9.23

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

225

1456

1.57

9.18

2.4

2.3

0.05

0.04

g/l

0.12

211

1310

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

452

3359

1.38

9.06

3.0

2.7

52.57

60.73

ml/min/173m2

5.35

212

1414

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

595

4626

1.32

8.87

3.1

2.6

8.06

9.82

umol/l

1.10

508

3998

(40760888) Immunoglobulin light chains.free panel - Serum

200

1282

1.58

8.52

2.9

3.4

—

(3037121) Protein [Mass/volume] in Urine

236

1572

1.53

8.48

3.6

2.8

0.44

0.30

g/l

1.03

116

620

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

672

1.80

8.47

1.3

—

(3025159) Blasts/100 leukocytes in Blood

425

3164

1.37

8.43

4.5

3.9

0.49

0.19

0.53

124

946

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1526

1.53

8.42

2.3

2.2

36.47

37.20

g/l

0.98

200

1290

(3000494) Fungus identified in Specimen by Culture

583

4553

1.32

8.41

1.5

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

561

1.87

8.29

3.3

2.3

1246.67

2227.48

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

211

1379

1.55

8.28

3.8

3.4

—

(40768797) Stomach Pathology biopsy report

698

5596

1.29

8.26

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

512

1.91

8.26

1.3

1.5

—

(3019225) pH of Specimen

599

4708

1.31

8.24

5.3

4.5

—

(3034426) Prothrombin time (PT)

102

3.15

8.21

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

670

5349

1.29

8.19

5.3

4.7

33.38

33.23

0.13

452

3481

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

262

1802

1.48

8.08

4.7

4.1

24.58

24.92

mmol/l

0.93

236

1616

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

701

5644

1.28

8.02

10.7

8.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

156

957

1.65

7.97

2.1

1.8

11.78

12.06

mg/l

0.15

138

868

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

142

2.76

7.95

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

3.43

7.93

5.5

5.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

195

1268

1.56

7.84

1.4

—

(3020891) Body temperature

279

1955

1.45

7.83

4.9

4.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

125

729

1.73

7.72

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

443

3367

1.35

7.70

4.5

3.9

0.11

0.05

139

1143

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

198

2.44

7.64

1.1

365.64

291.28

mg/l

0.71

169

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

200

1322

1.53

7.49

2.5

2.3

0.00

g/l

-0.00

189

1202

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

100

552

1.83

7.45

1.3

1.1

—

(40768804) Tissue Pathology biopsy report

1801

16085

1.19

7.43

2.3

2.2

—

(3017181) Myelocytes/100 leukocytes in Blood

462

3552

1.33

7.43

4.5

3.9

0.92

0.96

0.16

159

1322

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

213

2.36

7.43

1.2

1.1

52.43

41.94

mg/l

0.67

177

(3021879) Hepatitis B virus core Ab [Presence] in Serum

278

1968

1.44

7.40

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

115

664

1.75

7.38

1.4

1.5

1164.11

1824.69

e6/l

1.96

478

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

525

1.84

7.37

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

118

687

1.73

7.35

2.4

1.3

0.89

0.84

nmol/l

0.32

566

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

113

650

1.76

7.35

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

171

1097

1.58

7.32

1.5

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

679

5507

1.27

7.29

1.2

17.14

14.32

u/ml

0.32

221

1928

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

506

1.85

7.27

1.3

1.1

287.98

291.10

u/ml

0.04

312

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.78

7.20

1.7

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1351

1.52

7.18

2.5

2.3

0.00

g/l

0.36

189

1209

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

230

2.27

7.11

1.2

27.60

26.22

u/l

0.08

198

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

840

7004

1.24

7.07

1.3

1.2

1.85

1.80

u/ml

0.04

196

1723

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

163

1044

1.58

7.04

1.6

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

357

2.00

7.01

1.1

—

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

242

1692

1.45

6.91

3.1

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

105

608

1.74

6.71

7.0

6.0

11.09

12.35

mg/l

1.78

551

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

608

1.74

6.71

1.4

1.5

62531.73

58121.20

e6/l

0.06

361

(3000093) Morphology [Interpretation] in Blood Narrative

420

1.89

6.66

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

480

3776

1.30

6.55

2.7

2.4

34.83

38.57

u/l

0.70

395

3213

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

119

721

1.67

6.46

4.5

3.0

—

(4200892) Spirometry reversibility

375

2859

1.34

6.41

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

530

1.77

6.30

1.9

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

243

2.15

6.27

1.2

105.40

98.03

u/l

0.18

213

(3015171) Extractable nuclear Ab [Units/volume] in Serum

188

1277

1.49

6.25

1.2

0.32

1.15

u/ml

1.47

123

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

513

1.77

6.11

1.3

297.38

334.06

u/l

0.26

482

(3051593) INR in Capillary blood by Coagulation assay

266

2.08

6.08

8.6

13.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

414

3229

1.31

6.03

4.0

3.8

0.76

0.70

0.21

135

1136

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

165

2.37

5.95

3.2

2.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1511

13493

1.17

5.94

4.8

4.7

22.31

22.07

0.24

791

7100

(40761535) Cells panel - Urine sediment

482

3843

1.28

5.94

4.3

3.6

—

(3019977) pH of Arterial blood

290

2.01

5.88

1.6

2.4

7.42

7.43

0.05

105

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

115

712

1.63

5.78

1.2

4.93

7.64

u/ml

0.25

(3038515) Glucose [Moles/volume] in Venous blood

164

1103

1.50

5.75

3.8

3.5

7.87

7.64

mmol/l

0.43

159

1077

(3049717) Cytology report of Urine Cyto stain

279

2072

1.37

5.69

2.6

2.9

—

(3012441) Differential panel - Pleural fluid

585

1.69

5.67

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

324

1.92

5.57

1.4

1.2

22.20

27.58

iu/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

139

909

1.54

5.56

1.6

—

(3011648) Oxygen content in Venous blood

339

1.90

5.52

2.2

1.7

10.68

10.66

0.02

339

(3048689) Calprotectin [Mass/mass] in Stool

472

3790

1.27

5.50

2.1

2.0

147.40

161.88

ug/g

0.34

368

2958

(3003434) Protein [Mass/volume] in Pleural fluid

121

769

1.59

5.49

1.5

29.95

31.28

g/l

0.59

107

683

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

129

834

1.56

5.44

1.3

1.2

33.66

3.18

u/ml

0.65

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

137

898

1.54

5.43

1.3

1.2

53.24

36.12

u/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

399

1.82

5.41

3.7

3.0

74.42

25.16

mg/l

1.20

301

(36660697) Celiac disease serology panel - Serum

329

2528

1.32

5.36

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

141

933

1.53

5.36

3.3

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

180

1252

1.45

5.36

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

130

845

1.55

5.36

1.3

1.2

2.71

6.42

u/ml

1.34

135

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

239

2.06

5.35

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

239

2.06

5.35

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

423

1.78

5.32

1.2

59.48

65.84

u/l

0.51

383

(3017732) Neutrophils [#/volume] in Blood

335

2586

1.32

5.29

2.6

3.3

5.32

5.85

e9/l

0.37

242

1960

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

274

2057

1.35

5.24

4.8

4.7

1.56

1.59

0.18

261

1927

(3004616) Nuclear Ab [Presence] in Serum

449

1.75

5.18

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

136

901

1.52

5.16

2.3

2.6

29.94

34.89

umol/l

1.85

124

796

(3022493) Free Hemoglobin [Mass/volume] in Plasma

184

2.18

5.08

1.9

4.9

88.81

71.76

mg/l

0.44

128

(3008037) Lactate [Moles/volume] in Venous blood

167

1159

1.46

5.05

3.8

3.4

1.64

1.62

mmol/l

0.06

162

1128

(3020876) Protein [Mass/time] in 24 hour Urine

528

1.68

5.04

2.4

1.42

1.24

g/24h

0.29

256

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

157

1080

1.47

4.98

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

280

2128

1.33

4.95

1.9

1.48

2.14

ug/l

0.80

240

1838

(3051611) Lipemic interference index of Serum or Plasma

471

1.71

4.93

3.1

3.3

—

(3024932) HLA-DR beta [Type]

2.87

4.91

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

187

2.15

4.89

1.1

—

(3017704) Immunofixation for Urine

276

1.93

4.86

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

157

1086

1.46

4.85

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

182

1297

1.42

4.79

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

159

1106

1.45

4.77

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

342

1.82

4.77

2.5

2.1

629.87

646.47

0.15

211

(3014765) Yersinia sp identified in Stool by Organism specific culture

158

1099

1.45

4.75

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.73

4.74

1.2

1.0

—

(3024471) HLA-A [Type]

2.79

4.70

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

266

2029

1.33

4.61

4.8

0.87

0.88

0.04

251

1903

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

413

1.73

4.59

2.1

1.88

1.80

u/field

0.04

137

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

1291

1.41

4.59

3.5

3.1

0.80

0.81

nmol/l

0.24

143

965

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

147

2.25

4.56

1.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

147

2.25

4.56

1.7

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

188

1361

1.40

4.54

5.2

4.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

155

1084

1.44

4.54

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

155

1084

1.44

4.54

1.3

—

(21494755) Public health laboratory ask at order entry panel

1428

0.64

4.44

1.3

1.4

—

(3014891) Appearance of Pleural fluid

2.77

4.44

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

175

2.12

4.43

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

537

1.61

4.28

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.49

4.24

1.1

1.3

—

(3000330) Specific gravity of Urine by Test strip

305

2400

1.29

4.23

4.7

3.8

—

(3002256) Pathology report gross observation

638

5444

1.20

4.19

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

461

3811

1.23

4.19

5.0

4.0

1.23

mmol/l

0.82

400

3334

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

500

4171

1.22

4.16

2.3

2.1

0.20

g/l

0.05

465

3850

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

160

2.13

4.14

1.1

0.98

1.18

u/l

1.94

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

259

2003

1.31

4.10

3.2

4.21

4.38

pmol/l

1.98

228

1734

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

236

1.91

4.09

1.8

1.7

1.19

2.19

u/field

1.44

156

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

489

1.63

4.09

1.5

1.3

274.79

296.15

pmol/l

0.25

411

(3011985) Renin [Units/volume] in Plasma

521

1.60

4.06

1.4

55.43

63.64

mu/l

0.14

460

(3016750) Collection duration of Urine

230

1.92

4.05

2.5

1.9

487.81

489.80

min

0.04

160

(40761536) Microorganisms panel - Urine sediment

417

3428

1.24

4.00

5.1

4.4

—

(3022145) Colonoscopy Study observation

527

4438

1.21

3.99

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

327

1.75

3.92

1.6

1.3

77.50

62.41

titre

—

(3041354) Potassium [Moles/volume] in Venous blood

104

694

1.51

3.91

2.5

2.4

4.15

4.12

mmol/l

0.30

104

686

(3035285) Chloride [Moles/volume] in Venous blood

104

694

1.51

3.91

2.5

2.4

105.45

105.70

mmol/l

0.21

104

686

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

127

883

1.45

3.89

1.4

1.2

546.82

554.96

mg/l

0.08

116

826

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

118

810

1.47

3.87

1.8

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

149

1069

1.41

3.85

2.0

1.5

—

(1761868) Lipid panel - Serum or Plasma

1200

10826

1.14

3.85

3.6

3.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

243

1882

1.31

3.83

1.2

87.03

129.19

iu/ml

1.53

640

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

337

1.73

3.83

1.6

1.3

388.57

327.89

titre

—

(3022621) pH of Urine by Test strip

355

2885

1.25

3.80

3.4

3.3

—

(3022689) Creatine [Moles/volume] in Urine

2.43

3.79

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

103

691

1.50

3.79

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

173

2.03

3.78

4.2

2.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.01

3.76

1.5

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

112

766

1.47

3.75

1.3

45.74

46.32

u/l

0.02

670

(3005322) IgE [Units/volume] in Serum or Plasma

237

1835

1.31

3.75

1.3

211.15

218.69

u/ml

0.07

224

1667

(3033705) Calcium.ionized [Moles/volume] in Venous blood

102

685

1.50

3.74

2.5

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

316

2539

1.26

3.73

2.6

2.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

510

1.58

3.71

1.5

0.69

0.84

g/l

0.49

382

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

112

769

1.47

3.68

1.4

1.2

3.92

3.83

mmol/l

0.35

101

709

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.83

3.68

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

145

1045

1.40

3.67

1.7

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

6.67

3.67

1.1

—

(3051651) Icteric interference index of Serum or Plasma

253

1.83

3.66

3.7

3.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

504

1.58

3.65

1.1

33.82

404.08

iu/ml

0.54

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

608

1.52

3.64

1.2

68.43

50.22

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

199

1510

1.33

3.64

5.4

5.6

1.28

1.35

mmol/l

0.46

178

1351

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

489

1.58

3.63

3.8

3.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

129

2.18

3.63

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

482

1.59

3.61

1.1

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

397

1.65

3.59

1.6

32.69

24.94

u/ml

0.40

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

668

1.49

3.56

1.8

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

668

1.49

3.56

1.8

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

398

1.64

3.56

1.3

10.45

12.71

u/l

0.80

361

(3040151) Glucose [Moles/volume] in Capillary blood

581

1.52

3.51

93.6

5.9

7.33

7.29

mmol/l

0.04

476

(3028679) Herpes simplex virus Ab [Presence] in Serum

118

2.21

3.50

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

250

1.81

3.48

2.5

2.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

109

755

1.45

3.45

1.4

1.3

8.49

26.81

e6/l

1.30

582

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

109

756

1.45

3.43

1.5

1.4

1695.36

843.25

e6/l

0.35

617

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

126

2.15

3.41

2.7

2.2

159.96

165.98

0.11

116

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

373

1.64

3.38

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

373

1.64

3.38

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

373

1.64

3.38

1.7

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

150

1105

1.37

3.36

1.6

13918.51

14580.71

e6/l

0.11

113

789

(21491868) Cryoglobulin [Mass/volume] in Serum

127

2.13

3.35

1.1

1.3

—

0.45

g/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

597

5168

1.18

3.34

3.5

4.0

16.46

23.38

ug/l

0.54

491

4314

(3036782) Glucose [Moles/volume] in Pleural fluid

508

1.54

3.33

1.5

1.4

6.85

6.31

mmol/l

0.78

467

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

524

1.54

3.33

1.2

1.3

0.60

0.67

nmol/l

1.67

498

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

321

1.69

3.33

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

291

1.73

3.33

1.1

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

141

2.06

3.31

1.2

159.17

158.69

mmol/24h

0.01

141

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

135

2.08

3.27

1.3

11.79

23.26

2.90

111

(3010421) pH of Blood

164

1233

1.34

3.24

4.3

4.5

7.41

7.42

0.99

141

1118

(40768806) Pleura Pathology biopsy report

585

1.50

3.22

1.5

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

4.17

3.19

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.25

3.12

2.1

2.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

614

1.47

3.12

1.9

2.3

32.51

32.78

0.24

607

(3045788) Cell count panel - Pleural fluid

517

1.52

3.10

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

2.20

3.08

1.4

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

247

1.75

3.02

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

218

1.80

3.00

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

218

1.80

3.00

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.30

3.00

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

134

990

1.36

2.99

1.8

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

113

812

1.40

2.98

1.7

2.93

4.17

iu/l

1.91

237

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

348

1.62

2.95

1.1

—

1.83

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

381

1.58

2.90

1.4

12.65

13.07

u/l

0.20

364

(3003694) ABO and Rh group [Type] in Blood

1084

9881

1.12

2.88

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

115

2.09

2.88

1.5

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

536

1.48

2.84

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

100

710

1.42

2.84

2.9

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

275

1.68

2.83

1.6

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

148

1125

1.33

2.76

3.0

2.8

—

(1616796) Gas panel - Central venous blood

141

1066

1.33

2.74

4.3

3.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

766

1.39

2.73

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

457

3938

1.18

2.73

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.72

5.3

6.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

633

1.43

2.71

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

461

1.50

2.69

1.2

1.3

—

nmol/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

318

1.61

2.68

1.2

1.3

6.28

6.97

g/l

0.68

223

(3024139) IgG subclass 3 [Mass/volume] in Serum

318

1.61

2.68

1.2

1.3

0.37

0.44

g/l

1.07

222

(3028192) IgG subclass 2 [Mass/volume] in Serum

318

1.61

2.68

1.2

1.3

2.79

2.92

g/l

0.19

222

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

660

1.42

2.67

1.6

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

168

1.85

2.66

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

288

1.64

2.65

1.1

1.2

194.55

141.91

titre

0.18

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

288

1.64

2.65

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.79

2.64

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

157

1214

1.30

2.61

1.5

1.4

241.60

272.33

ug/g

1.20

100

734

(3007566) Smooth muscle Ab [Titer] in Serum

122

910

1.35

2.61

1.1

1.2

64.29

94.23

titre

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

613

1.43

2.60

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

244

1.69

2.59

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

490

1.48

2.58

2.7

2.5

—

(3019174) dRVVT (LA screen)

3.60

2.57

1.1

1.2

—

(4062490) Immunoglobulin typing, IgG

322

1.59

2.57

1.2

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.00

2.56

2.9

3.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.46

2.54

4.3

5.0

406.67

345.64

umol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

2.52

1.4

—

(3047189) Immunofixation for 24 hour Urine

254

1.66

2.51

1.5

1.6

—

(3008898) HLA-B27 [Presence]

105

773

1.37

2.46

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.14

2.44

1.1

1.2

0.34

0.30

g/l

1.13

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.17

2.40

1.3

1.2

80.10

82.40

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

179

1425

1.27

2.40

1.4

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.12

2.38

5.3

6.3

—

(40767503) Oxygen content in Capillary blood by calculation

134

1029

1.31

2.38

3.3

2.6

15.88

15.82

0.05

540

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

6.25

2.37

2.0

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.15

2.34

1.3

1.2

90.27

82.87

0.49

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

253

1.63

2.29

1.6

6.31

7.62

u/l

0.24

209

(3023410) Appearance of Cerebral spinal fluid

316

1.56

2.29

1.9

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.89

2.25

4.4

3.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

216

1.67

2.25

2.3

2.1

561.68

511.63

e6/l

0.21

185

(3045414) Leukocytes [Presence] in Urine

222

1831

1.22

2.19

2.2

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

130

1008

1.30

2.18

3.7

31.38

30.77

mg/l

0.06

658

(3000285) Sodium [Moles/volume] in Blood

2.24

2.17

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

188

1.71

2.16

1.3

1.2

—

(3012501) Base excess in Blood by calculation

136

1062

1.29

2.16

4.5

4.7

2.40

2.75

mmol/l

0.86

730

(3013290) Carbon dioxide [Partial pressure] in Blood

136

1062

1.29

2.16

4.5

4.7

4.97

5.01

kpa

0.24

127

1041

(3000492) Spirometry study

367

3174

1.17

2.15

1.5

—

(3012898) Urea [Moles/volume] in Urine

2.78

2.13

1.1

1.2

130.20

156.79

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

414

3618

1.16

2.12

1.5

—

(3000012) Reticulocyte production index

102

768

1.33

2.11

2.0

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.21

2.10

1.3

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

110

839

1.32

2.09

1.7

—

(3017569) Oxygen content in Arterial blood

268

1.57

2.08

1.9

2.0

—

(3027315) Oxygen [Partial pressure] in Blood

136

1069

1.28

2.07

4.5

4.8

8.40

8.35

kpa

0.16

127

1047

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

506

1.41

2.06

3.4

3.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.50

2.05

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.50

2.05

1.9

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

176

1.71

2.05

2.4

2.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

161

1.74

2.05

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

391

1.46

2.03

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

279

1.55

1.99

1.5

1.2

2.46

2.15

mmol/l

0.35

259

(3016038) Potassium [Moles/volume] in Urine

328

1.50

1.98

1.4

1.2

33.63

33.77

mmol/l

0.02

265

(3006184) Hemoglobin [Mass/volume] in Capillary blood

139

1103

1.27

1.97

2.8

2.2

125.79

126.45

g/l

0.12

114

795

(3044941) Cell count panel - Synovial fluid

717

1.33

1.96

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

273

1.54

1.94

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

446

1.42

1.92

1.3

109677.48

105496.84

e6/l

0.02

304

(3016650) Hepatitis A virus Ab [Presence] in Serum

505

1.39

1.92

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

347

1.47

1.91

1.5

1.2

—

(3045424) Erythrocytes [Presence] in Urine

697

1.33

1.86

1.6

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

136

1.77

1.86

2.3

1.9

28.99

220.81

ug/l

0.47

125

(3028271) Lactate [Moles/volume] in Capillary blood

101

776

1.31

1.86

2.2

1.9

1.75

1.70

mmol/l

0.12

759

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

285

1.51

1.84

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

367

1.45

1.83

1.5

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

459

1.40

1.83

1.1

—

(3014271) Vancomycin [Susceptibility]

326

1.48

1.83

2.6

3.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.06

1.80

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.92

1.79

1.1

1773.22

1578.35

miu/ml

0.21

(3029075) Extractable nuclear Ab panel - Serum

1.96

1.79

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

504

1.37

1.78

3.6

4.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

239

1.55

1.78

1.9

2.2

23.00

223.18

ug/min

1.26

(3027923) C peptide [Moles/volume] in Serum or Plasma

184

1.63

1.78

1.1

1.2

1.04

1.26

nmol/l

0.92

143

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

146

1.72

1.77

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

548

1.36

1.76

1.5

61.44

63.68

0.21

349

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

698

1.31

1.72

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

423

1.40

1.71

1.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

171

1.64

1.70

2.0

1.6

—

(3006462) Nitrate [Presence] in Urine

211

1.57

1.67

3.9

4.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

121

968

1.26

1.66

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

188

1.60

1.65

1.9

1.7

—

(3021788) Differential panel - Synovial fluid

102

800

1.28

1.64

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

363

3209

1.14

1.64

1.9

1.7

1.56

1.55

0.04

298

2696

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.00

1.58

1.3

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

121

1.74

1.58

1.3

20.85

30.22

0.99

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.20

1.56

3.2

2.4

0.36

0.48

u/field

0.21

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.51

1.54

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

623

1.31

1.53

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.34

1.52

1.0

1.1

7.78

4.86

mmol/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

169

1.60

1.51

2.0

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

169

1.60

1.51

2.0

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.51

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

531

1.32

1.47

1.4

—

(3004451) EKG impression Narrative

243

1.48

1.46

1.4

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

211

1.52

1.45

1.6

1.4

11.41

7.43

u/l

0.27

173

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

228

1.49

1.43

3.7

3.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.82

1.41

15.1

6.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

205

1.52

1.40

4.4

2.6

42.55

37.12

0.92

123

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.18

1.39

1.8

1.4

43.80

43.54

umol/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

415

1.35

1.38

2.1

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

1.62

1.38

1.9

2.3

62.69

134.11

umol/l

1.54

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

451

1.33

1.36

1.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

451

1.33

1.36

1.8

1.4

—

(40768800) Prostate Pathology biopsy report

1169

0.80

1.35

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

120

1.67

1.34

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

232

1.47

1.33

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.47

1.33

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

128

1.64

1.33

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

147

0.48

1.31

1.0

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.46

1.31

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.46

1.31

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

130

1.62

1.26

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

107

1.68

1.25

1.2

1.3

106.75

130.11

nmol/l

0.41

(3050129) First trimester maternal screen panel - Serum or Plasma

191

0.52

1.25

1.2

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

441

1.32

1.24

2.1

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

372

1.35

1.23

1.1

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

270

1.41

1.23

4.4

5.3

17.48

60.73

u/ml

—

(40757373) Influenza virus identified in Isolate

100

1.70

1.23

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

672

1.25

1.22

1.7

1.8

4.34

4.61

mmol/24h

0.32

567

(3017354) Segmented neutrophils/100 leukocytes in Blood

495

1.30

1.22

3.1

3.7

59.92

56.98

0.44

397

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

628

1.26

1.21

2.2

2.0

21.27

25.14

mg/l

0.26

136

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

288

0.62

1.20

1.2

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

280

1.40

1.20

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

144

0.49

1.20

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

145

0.48

1.19

1.0

1.4

—

(40768441) Liver Pathology biopsy report

247

1.42

1.18

1.4

1.3

—

(3024263) Appearance of Synovial fluid

247

1.42

1.18

1.5

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.70

1.17

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

350

1.35

1.17

1.6

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.75

1.12

1.4

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1010

9575

1.07

1.12

3.2

3.3

0.78

0.81

ug/l

0.51

729

6845

(3009466) Valproate [Moles/volume] in Serum or Plasma

511

1.28

1.11

3.4

4.2

341.93

346.31

umol/l

0.07

428

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.96

1.11

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

1222

1.18

1.10

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

1548

1.16

1.10

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.38

1.09

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

329

1.34

1.08

1.8

1.9

10450.62

2834.59

u/l

0.32

126

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

144

1.53

1.08

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.87

1.07

2.5

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

859

1.20

1.05

1.7

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.12

1.05

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

156

1799

0.86

1.05

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

262

1.38

1.05

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

262

1.38

1.05

1.2

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

162

1.48

1.04

2.6

1.6

60.18

56.16

ug/l

0.14

154

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

347

3805

0.91

1.03

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.27

1.03

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

367

1.31

1.03

1.1

1.4

—

(3039000) Anion gap in Blood

127

1083

1.18

1.02

6.5

6.3

11.15

11.17

mmol/l

0.02

117

968

(3018572) Chloride [Moles/volume] in Blood

127

1083

1.18

1.02

6.5

6.3

105.05

105.02

mmol/l

0.03

117

968

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.89

1.01

1.1

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

155

1.49

1.00

1.1

205.67

520.68

ng/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.88

1.00

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.88

1.00

1.4

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

222

1.40

1.00

1.5

58.00

67.91

0.69

183

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

123

1.55

0.99

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

405

1.29

0.98

1.3

8.15

7.69

mmol/l

0.50

337

(3004809) Band form neutrophils/100 leukocytes in Blood

820

1.20

0.98

3.6

1.48

1.69

0.26

703

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

110

931

1.19

0.98

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.97

1.4

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

232

1.38

0.97

1.0

1.1

1.16

1.19

u/ml

0.01

113

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.95

0.97

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.95

0.97

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.95

0.97

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

108

1.58

0.96

14.6

6.5

—

(40762814) Titanium [Mass/volume] in Blood

1.65

0.94

2.6

2.1

2.46

3.34

ug/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

118

0.51

0.93

18.0

11.7

690.50

815.71

nmol/l

—

112

(3008295) Osmolality of Serum or Plasma

444

1.26

0.93

1.3

271.20

276.63

mosm/kgh2o

0.75

328

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.92

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

736

1.20

0.91

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

102

1.57

0.90

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

3.50

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

182

0.60

0.89

1.1

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.69

0.88

1.5

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

538

1.23

0.88

1.1

—

(3045142) Bone marrow Pathology biopsy report

511

1.24

0.88

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

584

1.22

0.87

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.00

0.87

4.3

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

195

1.39

0.86

1.7

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.67

0.85

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

138

0.58

0.83

3.5

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

257

1.33

0.82

1.1

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

276

1.31

0.80

2.0

34.75

38.19

0.66

271

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

747

1.18

0.80

1.4

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

181

1.38

0.79

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

181

1.38

0.79

1.1

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.67

0.78

1.1

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.67

0.78

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.1

—

(40768443) Skin Pathology biopsy report

207

1870

1.11

0.77

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

278

1.30

0.77

2.3

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

174

0.63

0.76

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

174

0.63

0.76

1.1

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

585

1.20

0.76

1.6

1.7

298.44

296.89

mu/l

0.02

542

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

195

1758

1.11

0.76

3.3

3.2

92.49

2053.48

u/ml

1.85

171

1493

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.70

0.75

2.7

2.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

149

1.41

0.75

3.6

2.5

26.20

29.65

umol/l

0.62

108

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.70

0.75

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

173

0.64

0.75

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

173

0.64

0.75

1.1

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.57

0.74

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.60

0.74

1.2

—

(4035726) Immunohistochemistry procedure

415

3878

1.08

0.74

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

818

1.16

0.74

3.9

3.5

57.03

58.59

0.50

818

(3017446) Testosterone [Moles/volume] in Serum or Plasma

294

2710

1.09

0.74

2.3

2.1

11.65

11.75

nmol/l

0.06

254

2349

(3011288) Drugs identified in Urine by Screen method

245

1.31

0.73

2.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

469

1.22

0.73

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.2

—

(4034850) Laboratory test

150

1337

1.13

0.72

14.2

11.4

—

(3020650) Glucose [Presence] in Urine

1.55

0.71

1.3

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

1.34

0.71

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.58

0.71

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

151

1.39

0.71

1.0

1.2

42.92

39.90

g/l

0.63

(21494434) Karyotype in Bone marrow

417

1.23

0.70

1.3

1.1

—

(1002224) Polysomnography panel

110

963

1.15

0.70

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.49

0.70

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

573

1.19

0.69

1.4

—

(3027008) Opiates [Presence] in Urine

364

1.24

0.69

2.4

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.68

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.68

1.6

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.68

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

693

0.84

0.67

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

102

1.47

0.67

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.54

0.66

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

366

1.23

0.66

2.4

1.9

—

(3027944) Amphetamines [Presence] in Urine

357

1.23

0.66

2.5

1.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.79

0.66

1.0

—

(3016879) Cocaine [Presence] in Urine

339

1.24

0.66

2.5

1.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

421

1.21

0.65

1.6

1.5

24.16

26.24

0.19

265

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

128

1.41

0.65

1.2

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

331

1.24

0.64

1.4

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

154

1.37

0.64

2.0

1.9

—

(3035880) pH of Pleural fluid

306

1.24

0.62

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.63

0.62

1.6

1.5

—

(3001729) Color of Synovial fluid

1.63

0.62

1.4

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

544

1.18

0.61

1.6

1.9

194.85

191.70

pmol/l

0.10

509

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

200

1.30

0.60

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

575

1.17

0.58

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.46

0.58

1.1

0.79

0.67

umol/24h

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.72

0.57

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

410

1.20

0.57

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

102

1147

0.89

0.57

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

577

1.16

0.56

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

1.39

0.56

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.51

0.56

1.3

1.6

—

(3006270) Folate [Moles/volume] in Blood

421

1.19

0.55

1.2

326.26

330.07

nmol/l

0.05

330

(3024522) Salmonella sp identified in Specimen by Organism specific culture

579

1.16

0.55

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

168

1.31

0.54

1.3

1024.29

257.05

ug/l

0.37

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

1.39

0.53

2.1

2.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.45

0.53

1.9

1.8

6.76

9.19

mg/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

498

1.17

0.52

1.2

1.3

198.97

211.33

miu/ml

0.05

173

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.43

0.52

1.2

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

517

1.16

0.52

1.1

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.50

0.51

1.5

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.50

0.51

1.0

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.46

0.50

1.2

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

575

1.15

0.50

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

262

1.22

0.48

2.0

1.7

78.09

91.01

umol/l

1.46

262

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

181

1675

1.08

0.48

3.0

4.0

43.16

90.49

u/ml

2.60

169

1601

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.46

0.46

1.6

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

768

1.12

0.46

1.4

1.7

43.91

44.29

nmol/l

0.05

729

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

300

1.20

0.46

1.0

281.46

306.40

ng/l

0.29

187

(3000764) Benzodiazepines [Presence] in Urine

365

1.18

0.46

2.4

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

1.24

0.44

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

147

1356

1.09

0.43

1.2

1.1

69.17

258.25

titre

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.61

0.43

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.38

0.42

1.4

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.38

0.42

1.4

1.5

135.92

144.60

ng/l

0.09

(3006922) Hepatitis E virus Ab [Presence] in Serum

194

1.24

0.41

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

194

1.24

0.41

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

271

2562

1.06

0.41

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.2

1.1

—

(40768793) Breast Pathology biopsy report

816

0.89

0.41

1.2

1.3

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.41

0.0

1.5

—

4.52

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.01

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

105

1.33

0.41

1.0

1.5

76.36

244.04

nmol/24h

0.81

105

(3047007) Chlamydophila sp Ab [Presence] in Serum

369

0.84

0.40

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.40

0.0

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.36

0.40

1.1

230.00

315.70

pmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.43

0.39

1.2

1.9

9.72

17.55

umol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

260

1.19

0.39

3.5

3.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

279

1.18

0.38

1.0

6.15

3.24

u/ml

0.31

123

(3023511) Choriogonadotropin [Units/volume] in Urine

124

1.29

0.38

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

192

0.78

0.38

1.9

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.29

0.36

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

207

1.21

0.36

1.4

1.2

—

(3033799) Differential panel - Peritoneal fluid

157

0.76

0.35

3.3

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

171

1.23

0.35

5.0

3.5

45.74

55.47

1.39

163

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.43

0.35

1.2

1.1

2.04

1.86

umol/24h

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

1.24

0.35

1.5

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

277

0.83

0.35

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

301

1.16

0.35

1.0

32.72

42.79

ng/l

1.15

186

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

209

1.20

0.34

1.4

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

1.16

0.33

1.0

701.35

696.54

ng/l

0.02

182

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.35

0.32

7.1

6.7

—

(44813793) Dust mix specific IgE antibody measurement

174

1.21

0.31

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

295

1.15

0.31

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

294

0.85

0.31

2.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

156

1.22

0.31

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

157

1479

1.06

0.30

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

409

1.13

0.30

1.1

—

11.32

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

296

1.15

0.30

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

111

1.26

0.30

1.1

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

292

0.86

0.29

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.23

0.29

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

186

1.18

0.27

1.3

6.54

6.14

mmol/l

0.36

175

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

327

1.13

0.27

1.1

0.55

1.80

u/ml

2.08

167

(3035933) Granulocytes/100 leukocytes in Blood

1.25

0.27

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

116

0.78

0.27

1.3

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.28

0.26

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.69

0.26

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

216

1.16

0.25

1.2

1.3

0.62

0.78

u/ml

0.18

127

(3009871) Measles virus Ab [Titer] in Serum

1.18

0.24

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.24

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.27

0.22

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

200

1.15

0.22

7.0

6.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

210

1.14

0.21

1.6

1.4

7.38

2.70

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.15

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

296

1.12

0.21

2.8

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

421

1.09

0.21

1.3

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

356

0.90

0.21

1.0

1.1

1.82

2.14

u/ml

0.17

111

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.20

0.0

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.20

0.0

7.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.21

0.19

1.7

1.6

8.43

9.20

ug/l

0.29

(3002523) Influenza virus A Ag [Presence] in Specimen

290

0.90

0.18

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

590

1.07

0.18

1.3

18.63

10.61

u/l

1.53

474

(3023323) Follitropin [Units/volume] in Serum or Plasma

538

0.93

0.17

1.4

1.3

34.21

31.54

iu/l

0.18

449

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.20

0.16

1.0

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

168

1.13

0.15

1.1

1.0

1.62

0.12

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1.15

0.15

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

274

1.10

0.15

1.0

1.1

1.14

1.43

u/ml

0.10

106

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

112

1.16

0.14

1.4

1.1

—

(3042631) Mycobacterium sp identified in Specimen

704

1.05

0.14

2.4

2.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

189

1.11

0.13

1.6

1.7

10.69

10.52

umol/l

0.01

122

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.17

0.13

1.0

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.17

0.13

4.2

1.5

3.71

5.89

ug/l

0.29

(3025018) Bordetella pertussis Ab [Titer] in Serum

138

0.87

0.13

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

442

1.06

0.13

1.4

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

109

0.83

0.13

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

109

0.83

0.13

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

109

0.83

0.13

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

109

0.83

0.13

1.1

—

(3025130) Human papilloma virus identified in Specimen

231

0.91

0.12

1.9

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

629

1.05

0.12

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

133

1.13

0.12

3.4

1.4

27.87

30.16

umol/l

0.44

128

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

395

0.94

0.12

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

191

1.10

0.11

1.0

1.1

4.44

2.35

u/ml

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

143

1.12

0.11

4.0

5.0

62.18

69.74

0.40

112

(4094501) Cardiovascular stress test using bicycle ergometer

108

1044

1.04

0.11

1.1

—

(40765096) Chromosome analysis panel by Banding

134

1.12

0.10

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

535

0.95

0.10

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1002

0.97

0.10

3.0

3.2

145.15

911.08

u/ml

1.79

917

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

154

1.10

0.10

1.2

1.4

1.61

1.55

g/l

0.46

154

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.11

0.09

1.6

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.11

0.09

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.09

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

635

0.96

0.09

1.7

1.6

—

(3036180) Methadone [Presence] in Urine

1.07

0.08

1.3

1.6

—

(3020491) Glucose [Moles/volume] in Blood

292

1.06

0.08

2.4

2.5

7.22

6.78

mmol/l

0.45

199

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

136

1.10

0.08

1.9

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.09

0.08

3.1

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

835

1.03

0.08

1.0

1.1

1.28

6.71

u/ml

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.04

0.08

3.4

1.1

16.22

15.93

umol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

104

1014

1.03

0.07

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

844

0.97

0.07

1.5

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

108

1.11

0.07

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

128

1307

0.98

0.07

1.8

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.10

0.06

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

335

1.05

0.06

1.9

2.0

1.78

2.01

ug/l

0.28

281

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

120

1.08

0.04

1.8

1.6

0.30

0.40

ug/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

209

1.05

0.04

1.0

1.1

4.60

1.85

u/ml

0.41

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

231

0.95

0.04

1.0

1.1

2.28

13.34

nmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

1.09

0.04

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

259

1.04

0.04

2.3

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

119

1174

1.01

0.03

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

129

0.93

0.03

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

401

0.97

0.03

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

118

0.93

0.02

1.4

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

208

0.96

0.02

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

127

0.94

0.01

1.3

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

899

0.99

0.01

2.1

1.7

4.86

4.12

mg/l

0.20

666

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.02

0.00

1.4

—

(3048879) Bone marrow aspiration report

145

1.03

0.00

2.1

1.5

—

(3015183) Erythrocyte sedimentation rate

104

0.96

0.00

1.1

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

156

1.03

0.00

2.2

1.5

14.51

8.80

ug/l

1.07

137

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

196

1.02

0.00

1.2

1.5

123.69

200.81

pmol/l

0.86

196

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

223

0.99

0.00

1.4

1.3

42.71

32.99

u/l

0.61

179

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

209

1.00

0.00

1.8

—

(4281824) Cell count and differential, peritoneal fluid

421

1.00

0.00

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

531

1.00

0.00

1.5

1.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.95

-0.00

3.5

3.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_RETIVASCOCCLUSION and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_RETIVASCOCCLUSION	1.174 [1.08, 1.28]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.142

During the follow-up period (1.1.1998 — 31.12.2019), 5754 out of 16475 females with H7_RETIVASCOCCLUSION died.

Males

Parameter	HR [95% CI]	p-value
H7_RETIVASCOCCLUSION	1.288 [1.17, 1.41]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 5940 out of 16228 males with H7_RETIVASCOCCLUSION died.

Mortality risk

Mortality risk for people of age

years, who have H7_RETIVASCOCCLUSION.

N-year risk	Females	Males
1	0.074%	0.199%
5	0.61%	1.392%
10	1.777%	3.547%
15	3.236%	6.767%
20	5.594%	11.494%

Relationships between endpoints

↥

Index endpoint: H7_RETIVASCOCCLUSION – Retinal vascular occlusion

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Retinal vascular occlusion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints